<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">ACS Omega</journal-id>
    <journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id>
    <journal-id journal-id-type="publisher-id">ao</journal-id>
    <journal-id journal-id-type="coden">acsodf</journal-id>
    <journal-title-group>
      <journal-title>ACS Omega</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2470-1343</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8340416</article-id>
    <article-id pub-id-type="doi">10.1021/acsomega.1c02569</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CpACpP: <italic>In Silico</italic> Cell-Penetrating
Anticancer Peptide Prediction Using a Novel Bioinformatics Framework</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Nasiri</surname>
          <given-names>Farid</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath2">
        <name>
          <surname>Atanaki</surname>
          <given-names>Fereshteh Fallah</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3346-324X</contrib-id>
        <name>
          <surname>Behrouzi</surname>
          <given-names>Saman</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath4">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1906-3912</contrib-id>
        <name>
          <surname>Kavousi</surname>
          <given-names>Kaveh</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath5">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5204-6145</contrib-id>
        <name>
          <surname>Bagheri</surname>
          <given-names>Mojtaba</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Peptide
Chemistry Laboratory, Department of Biochemistry, Institute of Biochemistry
and Biophysics (IBB), <institution>University of Tehran</institution>, Tehran 14176-14335, <country>Iran</country></aff>
      <aff id="aff2"><label>‡</label>Laboratory
of Complex Biological Systems and Bioinformatics (CBB), Department
of Bioinformatics, Institute of Biochemistry and Biophysics (IBB), <institution>University of Tehran</institution>, Tehran 14176-14411, <country>Iran</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>kkavousi@ut.ac.ir</email>. Tel: <phone>+98 (21) 8899
3978</phone>. Fax: <fax>+98 (21) 6640
4680</fax>.</corresp>
      <corresp id="cor2"><label>*</label>mail: <email>mojtabagheri@ut.ac.ir</email>. Tel: <phone>+98 (21) 6696 9255</phone>. Fax: <fax>+98 (21) 6640
4680</fax>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>25</day>
      <month>07</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>03</day>
      <month>08</month>
      <year>2021</year>
    </pub-date>
    <volume>6</volume>
    <issue>30</issue>
    <fpage>19846</fpage>
    <lpage>19859</lpage>
    <history>
      <date date-type="received">
        <day>17</day>
        <month>05</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>07</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2021 The
Authors. Published by American
Chemical Society</copyright-statement>
      <copyright-year>2021</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0011" id="ab-tgr1"/>
      </p>
      <p>Cell-penetrating
anticancer peptides (Cp-ACPs) are considered promising
candidates in solid tumor and hematologic cancer therapies. Current
approaches for the design and discovery of Cp-ACPs trust the expensive
high-throughput screenings that often give rise to multiple obstacles,
including instrumentation adaptation and experimental handling. The
application of machine learning (ML) tools developed for peptide activity
prediction is importantly of growing interest. In this study, we applied
the random forest (RF)-, support vector machine (SVM)-, and eXtreme
gradient boosting (XGBoost)-based algorithms to predict the active
Cp-ACPs using an experimentally validated data set. The model, CpACpP,
was developed on the basis of two independent cell-penetrating peptide
(CPP) and anticancer peptide (ACP) subpredictors. Various compositional
and physiochemical-based features were combined or selected using
the multilayered recursive feature elimination (RFE) method for both
data sets. Our results showed that the ACP subclassifiers obtain a
mean performance accuracy (ACC) of 0.98 with an area under curve (AUC)
≈ 0.98 vis-à-vis the CPP predictors displaying relevant
values of ∼0.94 and ∼0.95 via the hybrid-based features
and independent data sets, respectively. Also, the predicting evaluation
of Cp-ACPs gave accuracies of ∼0.79 and 0.89 on a series of
independent sequences by applying our CPP and ACP classifiers, respectively,
which leaves the performance of our predictors better than the earlier
reported ACPred, mACPpred, MLCPP, and CPPred-RF. The described consensus-based
fusion method additionally reached an AUC of 0.94 for the prediction
of Cp-ACP (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://cbb1.ut.ac.ir/CpACpP/Index">http://cbb1.ut.ac.ir/CpACpP/Index</uri>).</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Iran National Science Foundation</institution>
            <institution-id institution-id-type="doi">10.13039/501100003968</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>97009976</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>University of Tehran</institution>
            <institution-id institution-id-type="doi">10.13039/501100004481</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>NA</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ao1c02569</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ao1c02569</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Cancer
is recognized as a multifaceted disease and the second cause
of death in the United States, with the projection of about 2 million
new cases and over 500 000 deaths in 2020.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Despite the significant progress in the development of
chemotherapeutics, such treatments give rise to resistant cancer cells
and severe side effects,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> which therefore
make it indispensable to design and predict novel therapeutics with
selective mechanisms.</p>
    <p>Anticancer peptides (ACPs) are considered
promising to specifically
target diseased cells. These molecules are positively charged and
made of short to medium-size length of 5–30 amino acids, mainly
lysine (Lys) and arginine (Arg).<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref></sup> The ACPs are structurally
diverse α-helices and β-sheets often known for their lytic
activity on the anionic phosphatidylserine- (PtdSer) and glycoconjugate-
(such as mucins and gangliosides) rich cancer plasma membranes.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> The necrotic mechanism of ACPs was, however,
suggested to be responsible for the rise of resistant cells through
changing the membrane surface glycation pattern by, for instance,
omission of sialic acids.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Because of the
lytic activity of these sequences, the release of cancer intracellular
contents could additionally result in causing the activation of proinflammatory
cascades.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p>
    <p>Cp-ACPs are enabled to
selectively cross the cancer cell membrane
via the endocytosis and/or the passive pathway and trigger the apoptotic
signaling by targeting, e.g., the endoplasmic reticulum (ER) and mitochondrial
(mt) membranes.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> We recently showed that
the magainin 2 (MG 2) analogue can enter the A549 cells via direct
transduction, leading to the mt dysfunction likely in response to
ER stress.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> The DNA synthesis inhibition
and disruption of the unfolded protein response were also envisaged
for the activity behaviors of Cp-ACPs.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> The Lys/tryptophan (Trp)-rich KT2 peptide exhibited clathrin- and
caveolae-mediated endocytosis and induced apoptosis by autophagy inhibition
in HCT116 colon cells.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Also, L-K6, a
sequence primarily composed of Lys and leucine (Leu), could enter
the cytoplasmic space of MCF-7 via clathrin-dependent macropinocytosis,
localize in the cell nucleus, and trigger nuclear disruption.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Also, the anionic azurin truncated domain P28
selectively internalized into the solid tumor cell lines and resulted
in P53 activation and proliferation inhibition of cancer cells;<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> for more examples, see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">Table S1</ext-link> in the Supporting Information. In fact, the design and development
of such sequences that specifically promote death signaling is a significant
milestone to overcome the challenges associated with membranolytic
ACPs.</p>
    <p>The valued machine learning (ML) discipline in peptide
activity
prediction has received growing interest compared with the current
costly experimental screenings.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> To date,
several ML-based classifiers have been developed for the prediction
behaviors of either ACPs or CPPs, most of which utilize compositional-based
[e.g., atomic composition (ATC), amino acid composition/index (AAC/AAI),
dipeptide composition (DPC)] and physicochemical-based features to
encode peptide sequences. In this context, support vector machines
(SVMs),
random forest (RF), extremely randomized tree (ERT), kernel extreme
learning machine (KELM), and neural networks (NNs), as well as different
subclasses thereof, such as the long short-term memory (LSTM), are
the frequently used algorithms.<sup><xref ref-type="bibr" rid="ref13">13</xref>−<xref ref-type="bibr" rid="ref15">15</xref></sup> Nonetheless, the development
of ML-based models capable of simultaneously recognizing both the
peptide-cell-penetrating and anticancer characters is certainly of
interest to predict and find therapeutics in multidrug-resistant cancer
therapy.</p>
    <p>In this study, we developed CpACpP(s) that were mainly
constructed
based on the fusion of two independent binary subclassifiers by utilizing
the SVM, RF, and XGBoost, which individually discriminate the anticancer
or plasma membrane transducing active sequences from their nonactivated
analogues, i.e., non-ACP (NACP) and non-CPP (NCPP) sequences. Various
feature sets were used, including AAC, DPC, grouped dipeptide composition
(GDPC), the composition of <italic>k</italic>-spaced amino acid group
pairs (CKSAAGPs), pseudo-amino acid composition (PAAC), amphiphilic
pseudo-amino acid composition (APAAC), physicochemical properties
(PCPs), composition-transition-distribution (CTD), <sup>13</sup>C
NMR, and their hybrids. The straightforward feature hybridization
and the three-layer feature selection algorithm of recursive feature
elimination (RFE) were applied on the training data to reduce the
model complexity and avoid multicollinearity and/or overfitting.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref></sup></p>
    <p>The independent analysis of Cp-ACPs revealed that our models
often
outperform the current ACP and CPP predictors, such as the Anticp,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> iACP,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> ACPred,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> and mACPpred,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> as
well as the CellPPD,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> MLCPP,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> CPPred-RF,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> and
SkipCPP-Pred.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> Taken together, our ML-based
models introduce a robust Cp-ACP identification and activity prediction
framework that may be of advantage, particularly in the current proteomics
investigations, for the development of novel multimodal peptide therapeutics
that selectively interfere with cancer cell signaling.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup></p>
  </sec>
  <sec id="sec2">
    <title>Results</title>
    <sec id="sec2.1">
      <title>Amino Acid Analysis</title>
      <p>The peptide primary structure,
defined by the amino acid composition and composite, could statistically
be used for the activity prediction and behaviors of ACPs and/or CPPs.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> Accordingly, we presented and analyzed the relevant AAC, DPC, and
tripeptide composition (TPC) features for each class of active and
nonactive anticancer and cell-penetrating sequences, as well as those
having both characters (<xref rid="fig1" ref-type="fig">Figures <xref rid="fig1" ref-type="fig">1</xref></xref>–<xref rid="fig3" ref-type="fig">3</xref>).</p>
      <fig id="fig1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Amino acid analysis of active and nonactive ACPs, CPPs, and Cp-ACPs.
The <italic>p</italic>-values were obtained by the Mann–Whitney
U test.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0002" id="gr2" position="float"/>
      </fig>
      <p>AAC analysis exhibited a high
frequency of Lys (∼16%), Leu
(∼14%), and Arg (∼9%) among the ACPs. Despite being
in low abundance, the presence of hydrophobic Phe and Trp was predominantly
obvious in the ACP sequences (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). Even though the most flexible alanine (Ala)/glycine
(Gly) and side-chain-branched Ile comprise ∼24% of the active
structure, the amino acid frequencies of tiny Ala, Gly, cysteine (Cys),
hydrophobic isoleucine (Ile), valine (Val), and basic histidine (His)
were almost indifferent between the ACPs and NACPs. The anionic aspartate
(Asp), glutamate (Glu), polar asparagine (Asn), glutamine (Gln), serine
(Ser), threonine (Thr), tyrosine (Tyr), methionine (Met), and α-helix/β-sheet-unfavored
proline (Pro) were primarily found in the NACPs. In comparison, the
CPPs were, particularly, Arg-rich (∼20%) and revealed remarkable
preference for the cationic Lys residue (∼12%). In contrast
to this evidence, we found that the aromatic Trp tilted to active
sequences, but rather almost equal contributions were found for the
hydrophobic (Phe, Ile, Leu, Met), polar (Asp, Pro, Glu, Ser, Thr,
Tyr), Ala, Cys, and His between the active and nonactive anticancer
sequences. Also, Asp, Glu, Gly, and Val were primarily observed in
the NCPPs.</p>
      <p>Intriguingly, the amino acid distribution pattern
for Cp-ACPs was
relatively biased toward the anticancer sequences in terms of the
total occurrence of basic Arg and Lys (∼26%), hydrophobic Leu
and Ile (∼19%), and Gly (∼9%) residues (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). Nonetheless, (i) similar
to that of active CPPs, the Arg residue adopted the higher fraction
of sequence composition in the Cp-ACPs; and (ii) the distribution
of each amino acid in the nonactive Cp-ACPs (NCp-ACPs) showed that
the existence chance of the aliphatic Ala, Val, and Met amino acids
and the polar Tyr, Thr, Gln, Glu, Asn, Asp, Pro, and His residues
increases in the NCp-ACPs relative to their Cp-ACP analogues.</p>
      <p><xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> shows the DPC evaluation of the first abundant dipeptides
in the active and nonactive sequences. The ACPs displayed dipeptides
that are biased toward X<sub>1</sub>–Y<sub>1</sub>, where X<sub>1</sub>/Y1 are Lys and/or Leu, vis-à-vis the NACPs mainly
anionic Glu/Asp-rich. Besides, Arg–Arg and the cationic pairs
of Ala, Gly, Ile, and Phe were relatively dominant in the ACP sequences.
The dipeptide composed of Arg and Lys was not among the active ACPs,
whereas Lys–Arg and Arg–Lys, as well as Arg–Arg,
Lys–Lys, and the cationic pairs containing Leu, were the most
abundant in the CPPs. The presence of His–His, Arg–His,
and Trp–Arg was as low as 1%, but nevertheless, they were predominantly
found in the active sequences as compared with the NCPPs. Obviously,
the NCPPs were characterized by the flexible dipeptides of Leu/Gly,
Ala/Gly, and Leu/Ser pairs, as well as Gly–Gly, charged Glu–Leu,
and Lys–Ile. We also recognized Arg–Arg, Leu–Leu,
Lys–Lys, Lys–Leu, Leu–Lys, Arg–Leu, Ile–Lys,
Gly–Gly, Arg–Lys, and Gly–Arg as the first 10
couples with the highest frequency of occurrence among the other pairs
in the Cp-ACPs. In this respect, the distribution of dipeptides was
relatively comparable to those of both the active ACP and CPP sequences.
With the exceptional Lys–Trp and flanked Gly–Arg, the
presence of other dipeptide residues, including Trp–Trp, which
is most probably found in the active Cp-ACPs,<sup><xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref27">27</xref></sup> occurred at the same level. In contrast, DPC analysis revealed that
the pair of hydrophobic residues, such as Ala, Leu, Ile, and Val,
has a higher frequency in the NCp-ACP sequences.</p>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Dipeptide analysis of
active and nonactive ACPs, CPPs, and Cp-ACPs.
The panels compare the most abundant dipeptides in the active (left
panel) and nonactive (right panel) sequences. The <italic>p</italic>-values were obtained by the Mann–Whitney U test.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0003" id="gr3" position="float"/>
      </fig>
      <p>The TPC analysis was performed over 8000 tripeptides to extract
the important functional motifs in the peptide activity interpretation
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>).<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> Accordingly, Lys-rich
AKK, LAK, KKL, LKK, and KLL were the first five plentiful combinations
in the ACPs. In contrast, LAG, AGI, ELV, LVS, and EDL comprised the
maximum forms of tripeptides in the NACPs. This evaluation showed
that the Arg-based tripeptides have remarkable values in the CPPs,
e.g., RRR, KKR, RKK, KRR, and RRQ; nonetheless, the frequency of KKK
and KLA even increased in these sequences. Unlike this observation,
the mainly hydrophobic-based compositions like LLG, AAL, YLL, GLL,
and AAA were dominant in the non-CPPs. Additionally, the Leu-rich
cationic tripeptides containing Arg and Lys were among the dominant
motifs in the Cp-ACPs. Furthermore, remarkable differences between
Cp-ACPs and NCp-ACPs were observed, suggesting that the TPC might
be regarded as an effective feature in the discrimination of active
and nonactive analogues. These findings suggested that the coexistence
of Arg and hydrophobic residues could conspicuously enhance peptide
internalization in the cancer cells.<sup><xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup> In this regard,
our previous investigation demonstrated that Trp-tagging promoted
the cellular entry of Arg-rich peptide into the melanoma cells giving
rise to no toxic effects.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> In fact, the
incorporation of Trp residues within the cationic sequences could
enhance the internalization efficiency of peptides through endocytosis.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup></p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Tripeptide analysis of active and nonactive classes of
anticancer,
cell-penetrating, and Cp-ACP sequences. The panels represent the most
frequently found tripeptides in the active (left panel) and nonactive
(right panel) sequences. The <italic>p</italic>-values were obtained
by the Mann–Whitney U test.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0004" id="gr4" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.2">
      <title>Physiochemical Characteristics</title>
      <p>The peptides’
PCPs (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>; also see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">Table S2</ext-link> in the Supporting Information), most importantly, the amphipathicity,
hydrophobicity, and net charge, play significant roles in the determination
of anticancer and cell-permeable peptide’s activity behaviors.<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup> Basically, the active sequences displayed a net positive charge
ranging from +5 to +6, whereas the NACPs, NCPPs, and NCp-ACPs were
among the neutral and weak positively charged analogues.</p>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Physicochemical
characteristics of the active and nonactive sequences.
Seaborn 0.10.0<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> was used to build the
plots. Other PCPs of interest are listed in the Supporting Information <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">Table S2</ext-link>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0005" id="gr5" position="float"/>
      </fig>
      <p>Given the more amphiphilic nature, strong interaction with and
deep penetration into the anionic lipid bilayers are expected for
the bioactive peptides, making the plasma membranes prone to disruption,
endocytosis, and/or direct translocation.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> This is interestingly in good agreement with the membrane binding
affinity of the ACPs, CPPs, and Cp-ACPs as revealed by the increased
Boman index (∼1.0–3.5) compared with the nonactive analogues.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> The peptides’ hydrophobic character followed
the order of CPPs≫ Cp-ACPs &gt; ACPs &gt; NACPs &gt; Cp-ACPs
≫
NCPPs, suggesting the importance of global hydrophobicity as a discriminatory
factor between each individual class of active and nonactive peptides.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup></p>
    </sec>
    <sec id="sec2.3">
      <title>Feature Selection</title>
      <p>Methods of feature
selection seek
to improve the prediction performance of the classification model.
In fact, the single feature selection might have specific biases<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> and be alleviated and/or compensated through
a feature selection algorithm via different strategies. Here, we applied
two independent feature selection methods to extract various feature
groups and test our ML models against them. Three well-known ML algorithms,
SVM, RF, and XGBoost, were exploited to construct the models. The
ML algorithms were fed with the well-curated features.<sup><xref ref-type="bibr" rid="ref36">36</xref>−<xref ref-type="bibr" rid="ref38">38</xref></sup></p>
      <p>In a straightforward feature combination approach (METH 1),
we ensembled different compositional, physicochemical, and <sup>13</sup>C NMR-based features. Previous studies suggested that AAC, PACC,
and PCP are the most effective features in predicting either ACPs
or CPPs.<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> The AAC displayed the best performance with
accuracy in the range of ∼0.95–0.96 [area under curve
(AUC) and F1 score ≈ 0.95] through the SVM-, RF-, and XGboost-based
ACP predictors (cf. <xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref> and <xref rid="fig6" ref-type="fig">6</xref>). In this regard, the subclassifiers could reach
the highest accuracy of 0.94–0.95 (AUC/F1 score ≈ 0.95/0.94)
using the PCP. Comparable results were obtained by the PACC feature;
the accuracy, AUC, and F1 score of the predictors were ∼0.94–0.95.
On the other hand, the CPP subpredictors presented their best performance
with accuracy in the range of 0.87–0.88 and AUC and F1 score
≈ 0.88 when SVM, RF, and XGboost applied the PCP descriptors.
The AAC-based subpredictors could also show important achievements
with an accuracy of ∼0.83–0.84 (AUC/F1 score ≈
0.84). Good performance (i.e., accuracy ≈ 0.82–0.83;
AUC ≈ 0.83; and F1 score ≈ 0.82) was obtained using
the PAAC-based CPP predictors.</p>
      <fig id="fig5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Performance metrics of RF (black), SVM
(red), and XGBoost (green)
models in response to various feature sets employed for the prediction
of ACPs.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0006" id="gr6" position="float"/>
      </fig>
      <fig id="fig6" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Feature-dependent performance metrics of RF
(black), SVM (red),
and XGBoost (green) for the prediction of CPPs.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0007" id="gr7" position="float"/>
      </fig>
      <p>To achieve the highest performance, we could also reach to set
the optimized combination of feature groups using the FeatureSelect.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Accordingly, we created seven hybrids, i.e.,
HYBR1 of 75-membered features (AAC, APACC, PACC), HYBR2 of 111-membered
features (AAC, APACC, PACC, PCP), HYBR3 of 115-membered features (AAC,
APACC, PACC, CNMR), HYBR4 of 151-membered features (AAC, APACC, PACC,
PCP, CNMR), HYBR5 of 150-membered features (AAC, APACC, CTD, PACC,
PCP), HYBR6 of 511-membered features (AAC, APACC, DPC, PACC, PCP),
and HYBR7 of 650-membered features (AAC, APAC, CSKAAG, DPC, GDPC,
PACC), that help our learners obtain better performance.</p>
      <p>Additionally,
we performed the RFE algorithm (METH 2) to find the
most statistically significant features for our predictions. The RFE
consecutively runs in several iterations and removes features of low
weights for each learner. In this respect, we managed to obtain 378
features for the ACPs and 128 features for the CPPs. Even though METH
2 considerably uses all feature sets, the results were comparable
to those obtained from HYBR2, in nearly all performance metrics (<xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref> and <xref rid="fig6" ref-type="fig">6</xref>), suggesting that either of the methods could be taken as
a competitor to one another. Intriguingly, we highlighted that the
features of a different nature could have synergistic effects on improving
the models’ performance. In the same sense, the <sup>13</sup>C NMR feature set exhibited low performance in the prediction task,
yet it played a positive role in improving the performance of our
predictors using METH 2 when some of its members are selected and
integrated with other attributes.</p>
    </sec>
    <sec id="sec2.4">
      <title>ACP and CPP Predicting
Classifiers</title>
      <p>The performance
of each learner on both ACP and CPP data is shown in <xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref> and <xref rid="fig6" ref-type="fig">6</xref>. Each model has been once trained and independently tested against
all extracted feature groups to find the impact of each on the performance
of our learners. Considering the above-mentioned approaches, the hybrid
feature-based classifiers displayed the best prediction accuracy,
especially in the CPP-based models, where they showed a steeper increase
in all performance metrics. The HYBR2-based SVM, RF, and XGboost often
revealed the best performance in terms of accuracy (∼0.97–0.99),
with AUC and F1 scores of about 0.98 and 0.98, respectively, for the
prediction of ACPs and CPPs (<xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref> and <xref rid="fig6" ref-type="fig">6</xref>). Given the very low
dimension feature space, HYBR2 is preferred over the hybrid features
in terms of ML complexity of the models’ train and test processes.
Interestingly, although the <sup>13</sup>C NMR feature showed low
performance from the prediction power’s point of view of both
the ACPs and CPPs, the negative impact of this feature group could
be spotted in the performance of HYBR3 and 4 feature sets. Notwithstanding,
the higher number of features gives a better clue to the ML-based
models that enable one to perform more accurate classifications. In
this regard, METH 2, which includes the advanced feature selection
procedure, allowed investigating the importance of each individual
feature in the original feature vector space. In fact, METH 2 utilizes
a combination of filter and wrapper selection methods to find those
features with a high discriminatory power. Even though HYBR2 (AUC
and/or accuracy of 0.99/0.96) and METH 2 (AUC and accuracy of 0.98/0.95
and 0.98/0.94, respectively) showed almost comparable results for
the ACP/CPP subpredictors (<xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref> and <xref rid="fig6" ref-type="fig">6</xref>), the former is described
by the smaller size of feature space, resulting in the lower ML time
complexity. In contrast, the feature selection by METH 2 could be
used in different contexts to obtain statistically important features.</p>
    </sec>
    <sec id="sec2.5">
      <title>Cp-ACP Data-Set Analysis through ACP/CPP Subclassifiers</title>
      <p>Relative to other feature sets, HYBR2, which encompasses a rather
low number of features, and METH 2 offer more reliable results to
predict Cp-ACPs through our developed ACP and CPP models (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>). The prediction performance (generalization power) of our
HYBR2-based and METH 2-based SVM, RF, and XGboost algorithms on the
Cp-ACP data set (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">Table S1</ext-link> in the Supporting
Information) demonstrated that the performance of our methods was
notably better than the current accessible ACP (i.e., Anticp,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> iACP,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> ACPred,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> and mACPpred<sup><xref ref-type="bibr" rid="ref21">21</xref></sup>) and
CPP (i.e., CellPPD,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> MLCPP,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and CPPred-RF<sup><xref ref-type="bibr" rid="ref24">24</xref></sup>)
tools. Compared with the average of other tested tools, the performance
metrics of all tested ACP-based predictors with HYBR2/METH 2 were
as follows: recall (0.90/0.59), F1 score (0.90/0.68), accuracy (0.90/0.73),
and Matthews correlation coefficient (MCC) (0.79/0.48). Nonetheless,
the HYBR2/METH 2-based CPP predictors presented a lower quality in
classifying Cp-ACPs on the basis of MCC values (0.60/0.51), yet their
predicting power was competitive with the previous tools, namely,
recall (0.79/0.64), F1 score (0.79/0.70), and accuracy (0.80/0.75).</p>
      <fig id="fig7" position="float">
        <label>Figure 7</label>
        <caption>
          <p>Performance
comparison measures of (a) ACP-based and (b) CPP-based
models constructed using RF (black), SVM (red), and XGBoost (green)
algorithms for prediction of Cp-ACPs. The column bars represent the
performance comparison of this study’s ACP and CPP subclassifiers
relative to (a) SVM-based Anticp, iACP, ACPred, mACPpred, and (b)
prediction tools of CellPPD (SVM), MLCPP (RF), CPPred-RF (RF), and
SkipCPP-Pred (RF). See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">Tables S3 and S4</ext-link> in the Supporting Information for details of numerical values.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0008" id="gr8" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.6">
      <title>ML-Based Fusion Method for Predicting Cp-ACPs</title>
      <p>It was
shown that the fusion or ensemble of multiple classifiers’
prediction outputs could improve the final performance.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> Importantly, from this perspective, numerous
ensemble-strategy-based models were suggested for the classification
of proteins. For instance, EnsDNN, which was developed for the protein–protein
interaction (PPI), utilizes a two-hidden-layer neural network to integrate
27 trained independent deep neural networks (DNNs).<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> The Rotation Forest was also implemented as the ensemble
classifier to predict PPIs.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> In this regard,
Nanni et al. additionally applied the weighted sum role as the ensemble
approach for the protein classification based on the sum of scores
obtained from the pool of SVM classifiers.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> Even though various ensemble predictors, such as iACP-GAEnsC,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> ACPredStackL,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> and
StackCPPred,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> are available to predict
the ACP and CPP sequences, there is no model that concurrently explores
both the anticancer and cell-penetrating properties of peptide sequences.
Therefore, we, in this study, proposed a parallel two-layer framework
upon which the results from the ACP and CPP predictors, individually
built on a separate layer using the same algorithms (i.e., RF, SVM,
and XGBoost) and feature selection methods (METH 1: feature hybridization;
METH 2: RFE algorithm), were combined to yield a fused decision of binary classifiers on the independent
validation test set of Cp-ACPs. Although, for instance, voting, statistical,
and fuzzy-logic-based methods could be applied for making the final
decision, we used a consensus hard-fusion-based strategy by running
a pessimistic “AND” operator for the assessment labeling
of each Cp-ACP.</p>
      <p>As illustrated in <xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>, our fusion method
for the HYBR2 and METH 2 feature groups managed to achieve average
AUCs of 0.95 and 0.94, respectively. Because of the simple nature
of hard-fusion applied on the classifier’s decisions, the predictive
power for this stage was slightly better than CPP-based machines.
In contrast, the performance of our predictors could not exceed that
of the ACP-based machines in predicting Cp-ACPs. Overall, the SVM
classifier had the highest MCCs of 0.68 and 0.64 using the HYBR2 and
METH 2 feature groups, respectively. In comparison, XGBoost presented
a competitive MCC of 0.63 on METH 2, but the RF classifier resulted
in the lowest quality with an MCC of 0.58 on HYBR2. Taken together,
the average precision (PR) values of 0.85 for HYBR2 and 0.83 for METH
2 prove that our simple fusion method could be profoundly considered
as a reasonable predictive power in classifying Cp-ACPs. Having said
that, we might expect improvements in the results by designing more
complex fusion methods and utilizing a higher number of validation
data.</p>
      <fig id="fig8" position="float">
        <label>Figure 8</label>
        <caption>
          <p>Performance metrics comparison of the intersection of ACP- and
CPP-based models in predicting Cp-ACPs.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0009" id="gr9" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Discussion</title>
    <p>Recent achievements in the design and development
of novel therapeutics
often failed to control and prevent cancer growth and metastasis as
a result of diseased cell heterogeneity and recurrence, as well as
the mechanisms of resistance (e.g., drug efflux, inadequate uptake
and inactivation, target modification, DNA damage repair).<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> With regard to this issue, the identification of novel therapeutics
that overcome the development of cellular resistance and selective
targeting of the neoplastic cells is challenging.</p>
    <p>Unlike normal
eukaryotic cells, cancer plasma membranes are negatively
charged and covered with a higher content of PtdSer and sialic acid-conjugated
proteins and lipids and a larger surface area of increased value of
microvilli, which are therefore appropriately considered as targets
for the action of dominantly cationic and amphipathic peptides (i.e.,
ACPs, CPPs).<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> These sequences are frequently
characterized by high occurrences of Arg and Lys, aliphatic Leu/Ile,
as well as other aromatic residues, such as Phe and Trp, giving rise
to the overall positive charge properties and sufficient hydrophobicity
for the peptide molecules’ optimal effects on cancer membranes.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> From the peptide–membrane interaction
perspective, however, the impact of each of these residues on the
anionic functional entities of the cell surface is distinct at the
molecular level. Upon the electrostatic binding of ACPs/CPPs to the
cancer membrane and further deep penetration into the hydrophobic
interior, the Arg and Lys side chains presumably maintain their positive
charge, but nevertheless, the guanidinium group more selectively binds
at the anionic lipid bilayer interface than the amino functional moiety.
This, however, depends on the sequence length and structure, leading
to the compensated free energy required for the direct cellular transduction
of relevant peptides.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> The guanidinium
side chain additionally tends to multiple hydrogen bonds with the
negatively charged molecules of the cell surface. That, as a consequence,
promotes the formation of a saddlelike curvature in the plasma membrane
and membrane endocytosis in peptides mainly constituting of Arg.<sup><xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref47">47</xref></sup> Notwithstanding, the Lys-rich MG 2-derived sequences exhibit either
direct membrane transport or endosomal delivery characteristics independent
of the lipid-raft structures in the A549 cells, with the eventual
peptide localization in the nucleus.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> By
comparison, the peptide containing Ile/Leu and Phe/Trp supports hydrophobic
contacts with the lipid bilayer core, resulting in an enhanced membrane
fluidity and perturbation. Moreover, the presence of these residues
in the context of a zipper-like structure may play a pivotal role
in the inhibition of cell regulatory protein–protein interaction
networks, as well as in the self-assembly-promoted membrane activity
of ACPs/CPPs.<sup><xref ref-type="bibr" rid="ref48">48</xref>−<xref ref-type="bibr" rid="ref51">51</xref></sup> Aside from this, the amphipathic indole ring could localize at the
polar/apolar lipid interface, resulting in the convenience of membrane
selectivity in the Trp-rich peptides.<sup><xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref51">51</xref></sup> With the high
occurrence of the flexible and tiny residues of Gly and Ala in the
Cp-ACPs, the increased plasma membrane interaction and cellular uptake
of the peptides are most likely expected.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup></p>
    <p>Even though recent studies have highlighted the cell membrane-lytic
effects of ACPs,<sup><xref ref-type="bibr" rid="ref52">52</xref>−<xref ref-type="bibr" rid="ref54">54</xref></sup> cancer cells characterized by a highly dense sialic
acid surface were supposed to become resistant to them.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> The release of proinflammatory cytokines and
chemokines is a further consequence of the relevant peptide-induced
compromised cell membranes.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> In contrast,
Cp-ACPs are known for their selective intracellular activity and are
capable of triggering apoptotic signaling via the modulation of protein–protein
interaction networks or nucleus DNA fragmentation;<sup><xref ref-type="bibr" rid="ref8">8</xref>−<xref ref-type="bibr" rid="ref12">12</xref></sup> see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">Table S1</ext-link> in the Supporting
Information for more examples. Because of their distinct anticancer
signaling, these peptide molecules would probably not face the emergence
of resistant cells.<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup> For instance, the bioactivity
of these sequences might probably not be influenced in P53-deficient
cells, as well as by the activity of multidrug-resistant efflux pumps,<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup> thus introducing Cp-ACPs as potential alternatives to address the
current obstacles in cancer therapy. In this respect, however, the
identification and design of Cp-ACP sequences always require rigorous
and challenging discovery of peptide/protein libraries using expensive
experimental screenings.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Notwithstanding,
there are several ML predicting tools focusing on ACPs or CPPs alone
without taking the specific activities of Cp-ACPs into consideration.<sup><xref ref-type="bibr" rid="ref18">18</xref>−<xref ref-type="bibr" rid="ref25">25</xref></sup> It is, therefore, of importance to develop ML-based models to predict
such bioactive sequences with novel anticancer functions.</p>
    <p>In
general, the existing ML-based ACP and CPP predictors are classified
into two main groups according to their used learning algorithms.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> The first group includes models employing the conventional ML-based
algorithms including but not limited to the SVM, RF, ERT, and KELM.
For instance, the SVM based on the PseAAC and local alignment kernel
was applied to develop ACP classifiers, where, accordingly, four novel
anticancer sequences were derived from the HIV-1 P24 protein.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> Likewise, the SVM was used to implement both
AntiCP and mACPpred.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup> Also, Wei et al. developed ACPred-FL
through which 40 groups of features from seven different descriptor
classes (i.e., binary profile, overlapping property, and twenty-one-Bit
features, CTD, AAC, G-gap dipeptide, and adaptive skip dipeptide composition)
were fed into the SVM model to predict the model labels.<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> Additionally, ACPred-FUSE was built on the RF
algorithm based on multiview information composed of the class, probabilistic,
and sequential information.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> Last but
not least, ACP-DL<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> and DeepACP<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> are the only deep-learning-based models that
can distinguish ACPs. The former employs the recurrent neural network
(RNN) with the LSTM method fed with a <italic>k</italic>-mer sparse
matrix and a binary profile encoding the peptide sequence into a two-dimensional
(2D) matrix<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> while the latter proposes
a sequence-based model utilizing the RNN architecture with a bidirectional
LSTM for training the prediction model.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> More recently, Charoenkwan et al. proposed iACP-FSCM as a novel
computational method to characterize ACPs according to the flexible
scoring card method, which could determine the propensity score of
local and sequential information in anticancer sequences.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> In this regard, CellPPD was developed using
the SVM, fed with various features, such as compositional information,
PCP, and binary profile, to classify the CPPs.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> Furthermore, CPPred-RF<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> and
SkippCPP-Pred<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> were two crucial RF-based
CPP classifiers. Whereas the former predictor was a two-layer architecture,
where the peptide-cell-penetrating characteristics and their uptake
efficiency are predicted in the first and second layers, respectively,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> the latter utilized the novel <italic>k</italic>-skip-2-g feature algorithm, which calculates the composition of
two residues with distances ≤ <italic>k</italic>, to encode
the CPP sequences.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> Besides, Manavalan
et al. developed MLCPPs, which apply a two-layer prediction design
using ERT and RF to predict CPPs and their uptake capability.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> Recently, TargetCPP was constructed based on
the gradient boost decision tree capturing four different features,
including composite protein sequence representation, split amino acid
composition, CTD, and information theory features, to predict CPPs.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> In contrast, the ensemble-learning-based methods
are considered as the second group of ACP/CPP classifiers. The examples
include iACP-GAEnsC, a genetic algorithm and majority-voting-based
ensemble,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> as well as ACPredStackL and
StackCPPred, applying a stacking framework to classify the ACP and
CPP sequences, respectively.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref44">44</xref></sup> In the development
of ACPredStackL, the <italic>k</italic>-nearest neighbor (KNN), naïve
Bayesian (NB), Light Gradient Boosting Machine (LightGBM), and SVM
were utilized as base learners using different features, e.g., AAC
and CTD. In the following, the prediction outcome of classifiers was
merged and fed to the logistics regression (LR) to create a metamodel
for the final prediction of ACPs.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> In
a comparable manner, StackCPPred comprised two-level algorithms, where
RF, KNN, SVM, LightGBM, and XGBoost were used in the first layer and
independently trained based on the residue pairwise energy content
matrix as the feature encoding tool, and the SVM, in the second layer,
was then trained using the classifiers’ combined prediction
outputs.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup></p>
    <p>Taken together, in this
study, we presented an approach that could
simultaneously examine both the anticancer and cell-penetrating properties
of peptide sequences. To this end, we developed two parallel independent
prediction pipelines that identify the ACPs from NACPs, as well as
the CPPs from their nonactive analogues, based on the comparable RF,
SVM, and XGBoost algorithms, and the same type of feature selection
ensembles. We further used a hard-fusion method based on the pessimistic
AND operator to integrate the prediction results of the ACP and CPP
subclassifiers and assess their combined power for the detection of
Cp-ACPs. Most studies provided simple train-test splitting methods
or one iteration of cross-validation for the evaluation of trained
models.<sup><xref ref-type="bibr" rid="ref63">63</xref>−<xref ref-type="bibr" rid="ref66">66</xref></sup> However, we applied 10 iterations of 10-fold cross-validation with
different random seeds to carry out an extremely rigorous assessment
of our models. This strategy thus permits one to (i) evaluate the
models’ predictive performance and obtain consistently low
variance and robust results when tested with diverse combinations
of data, (ii) improve the generalization power of our predictors,
and (iii) avoid the overfitting problem. Overall, our predictors mostly
outperform the current ML-based ACP/CPP models.</p>
    <p>The performance
of our machines was assessed with an independent
data set of 65 Cp-ACPs. To ensure a fair assessment of the models’
performance, these sequences were neither present in the training
data nor seen by the predictors. The hard-fusion of the ACP and CPP
subclassifiers that was used for the label assessment of each individual
peptide candidate exhibited an average AUC of ∼0.94 for the
identification of Cp-ACPs in an ensemble setting by our RF-, SVM-,
and XGboost-based models. Nevertheless, this simple fusion operator
might result in a higher false-negative (FN) rate and probably give
rise to the negative evaluation of a number of peptides with the Cp-ACP
properties. Thus, it is necessary to develop advanced and intelligent
ensemble methods, like the weighted majority voting, and improve the
models’ prediction performance. The limited number of experimentally
validated Cp-ACP training data set, in this study, is moreover a challenge
to build the decision-making systems based on the complex fuzzy integral
operator, such as the ordered weighted averaging. Nonetheless, the
tolerance of a more false-negative risk for less error in positive
prediction is desirable using a pessimistic operation, particularly
in laboratory applications. As a result, a peptide candidate that
has both anticancer and cell-penetrating properties could certainly
be selected with high reliability for further validation in wet-lab
experiments. Last but not least, our proposed approach and architecture
could potentially be exploited to facilitate the identification of
various classes of bioactive sequences with the cell-penetrating property.
The web-based CpACpP platform and the package containing the prebuilt
models are accessible at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://cbb1.ut.ac.ir/CpACpP/Index">http://cbb1.ut.ac.ir/CpACpP/Index</uri>.</p>
  </sec>
  <sec id="sec4">
    <title>Experimental Section</title>
    <sec id="sec4.1">
      <title>Data-Set
Preparation</title>
      <p>The anticancer and cell-penetrating
sequences were separately extracted from the existing databases as
mentioned below. Note that we filtered out the databases from those
sequences comprising non-natural amino acid residues. These experimentally
determined active sequences were taken without considering their activity
level. To improve the data statistical significance and the generalization
power of our predictors, the CD-HIT program was applied to remove
the sequences with a homology of more than 90%.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup></p>
      <sec id="sec4.1.1">
        <title>ACPs</title>
        <p>A 659-membered peptide sequence data set was collected
after running the CD-HIT program from the CancerPPD (an anticancer
peptide and protein database), APD (antimicrobial peptide database),
DADP (database of anuran defense peptides), and DBAASP (database of
antimicrobial activity and structure of peptides).<sup><xref ref-type="bibr" rid="ref68">68</xref>−<xref ref-type="bibr" rid="ref71">71</xref></sup> A data set of presumably accepted
657 NACPs was generated using the RandSeq tool (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://web.expasy.org/randseq/">https://web.expasy.org/randseq/</uri>), out of which 385 sequences were acquired from the AntiCP data
set<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">Table S5</ext-link> in the Supporting Information) following the CD-HIT run. The RandSeq
tool is able to generate sequences with the user-defined amino acids.
Given the different preference and frequency of each amino acid in
ACPs vs NACPs, the negative sequences could likely be generated with
a higher probability using this tool.</p>
      </sec>
      <sec id="sec4.1.2">
        <title>CPPs</title>
        <p>CPPsite2.0,
which contains around 1850 experimentally
validated natural sequences, was used for the analysis.<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> The NCPP data set was randomly acquired using
the RandSeq tool, as well as the KELM-CPPpred and MLCPP benchmarks<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref28">28</xref></sup> (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">Table S6</ext-link> in the Supporting Information).
The collected sequences after the CD-HIT run were, in total, 1180
sequences [CPPs (577) and NCPPs (603)].</p>
      </sec>
      <sec id="sec4.1.3">
        <title>Cp-ACPs</title>
        <p>This data
set contains 65 sequences having
both anticancer and cell-permeable properties and was selected from
the literature survey (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">Table S1</ext-link> in
the Supporting Information). This data set was taken as the independent
data set to evaluate and validate our methods. The RandSeq tool was
used for the generation of sequences having neither cell-penetrating
nor anticancer property. The CD-HIT was further applied to exclude
the Cp-ACPs with a similarity &gt;90% in either the ACP or CPP data
set.
Overall, 150 unique sequences [65 Cp-ACPs and 85 NCp-ACPs] were obtained
and used in this work.</p>
      </sec>
    </sec>
    <sec id="sec4.2">
      <title>Feature Extraction</title>
      <p>The AACs, PCPs,
and <sup>13</sup>C NMR feature-based groups were generated by IFeature,
modlAMP, and
IAMPE, respectively.<sup><xref ref-type="bibr" rid="ref36">36</xref>−<xref ref-type="bibr" rid="ref38">38</xref></sup></p>
      <p>For all of the calculated features in this
section, the query peptide is defined as <italic>P</italic> = <italic>P</italic><sub>1</sub><italic>P</italic><sub>2</sub><italic>P</italic><sub>3</sub>, ..., <italic>P</italic><sub><italic>L</italic></sub>, which is composed of a sequence of <italic>L</italic> amino acid
residues. <italic><sub>Pi</sub></italic> (<italic>i</italic> = 1,
2, ..., <italic>L</italic>) denotes the residue at the <italic>i</italic>th chain position. The feature vectors, their dimension, and a brief
description are provided next.</p>
    </sec>
    <sec id="sec4.3">
      <title>AAC-Based Features</title>
      <p>The frequency of naturally occurring
amino acids and their 400 dipeptide combinations are formulated in <xref rid="eq1" ref-type="disp-formula">eqs <xref rid="eq1" ref-type="disp-formula">1</xref></xref> and <xref rid="eq2" ref-type="disp-formula">2</xref>.<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m001" position="anchor"/><label>1</label></disp-formula><disp-formula id="eq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m002" position="anchor"/><label>2</label></disp-formula></p>
      <p><inline-formula id="d33e870"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m003.gif"/></inline-formula> and <inline-formula id="d33e873"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m004.gif"/></inline-formula> are the occurrence percentages of the amino
acid (<italic>i</italic> = 1, 2, ..., 20) and the dipeptide (<italic>i</italic> = 1, 2, 3, ..., 400), respectively, in the peptide. <italic>R<sub>i</sub></italic> and <italic>D<sub>i</sub></italic> are the
numbers of residue and dipeptide, respectively. Also, the amino acid
types are classified into five groups based on their aliphaticity
(<italic>g</italic><sub>1</sub>), aromaticity (<italic>g</italic><sub>2</sub>), and charge values, including positive (<italic>g</italic><sub>3</sub>), negative (<italic>g</italic><sub>4</sub>), and neutral
(<italic>g</italic><sub>5</sub>), and employed to calculate the GDPC
vector according to <xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula">3</xref></xref>.<disp-formula id="eq3"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m005" position="anchor"/><label>3</label></disp-formula></p>
      <p>Herein, <italic>N</italic><sub><italic>g</italic><sub><italic>i</italic></sub><italic>g</italic><sub><italic>l</italic></sub></sub> is the
number of occurrences of the paired amino acids from <italic>g</italic><sub><italic>i</italic></sub> and <italic>g</italic><sub><italic>l</italic></sub> groups in the query peptide (<italic>P</italic>),
where <italic>g</italic><sub><italic>i</italic></sub> and <italic>g</italic><sub><italic>l</italic></sub> are members of {<italic>g</italic><sub>1</sub>,<italic>g</italic><sub>2</sub>,<italic>g</italic><sub>3</sub>,<italic>g</italic><sub>4</sub>,<italic>g</italic><sub>5</sub>}.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup></p>
      <p>CKSAAGP, which measures the
occurrence frequencies of the <italic>k</italic>-spaced amino acid
pairs in the query peptide, is a feature
set and calculated according to <xref rid="eq4" ref-type="disp-formula">eq <xref rid="eq4" ref-type="disp-formula">4</xref></xref>. Briefly, a <italic>k</italic>-spaced amino acid pair
is represented as <italic><sub>Pi</sub></italic>{<italic>k</italic>}<italic>P</italic><sub><italic>j</italic></sub> (<italic>i</italic>, <italic>j</italic> = 1, 2, ..., 20), where <italic><sub>Pi</sub></italic> and <italic>P</italic><sub><italic>j</italic></sub> denote
any two residues of 20 amino acids separated by <italic>k</italic> residues (<italic>k</italic> = 0, 1, 2, 3, 4, 5).<disp-formula id="eq4"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m006" position="anchor"/><label>4</label></disp-formula></p>
      <p><inline-formula id="d33e1052"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m007.gif"/></inline-formula> is the number
of pair groups of amino acid
types <italic>i</italic> and <italic>l</italic> separated by <italic>k</italic> gaps in the sequence of the query peptide (<italic>P</italic>).</p>
      <p>Additional information including the correlation between
the residues
of a certain distance is accessible in APAAC and PAAC. These feature
sets use the hydrophobicity, hydrophilicity, and/or side-chain mass
indices to reflect the peptide sequence activity.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup></p>
      <sec id="sec4.3.1">
        <title>PCP-Based Features</title>
        <p>This class of features includes
atom-type composition (ATC) and various physicochemical attributes
of amino acids that form the peptide sequence. ATC encodes the frequency
of each atom containing C, H, N, O, and S in a specific peptide sequence.
The PCP feature set can be computed according to <xref rid="eq5" ref-type="disp-formula">eq <xref rid="eq5" ref-type="disp-formula">5</xref></xref>.<disp-formula id="eq5"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m008" position="anchor"/><label>5</label></disp-formula>where <italic><sub>Pi</sub></italic> and <italic>L</italic> are the values of multiple physiochemical properties of
amino acid type <italic>i</italic> and the length of the peptide sequence,
respectively. We calculated the fractions of tiny (A, C, D, G, S,
T), small (E, H, I, L, K, M, N, P, Q, V), large (F, R, W, Y), aliphatic
(I, L, V), aromatic (F, H, W, Y), polar (D, E, R, K, Q, N), charged
(D, E, K, H, R), basic (H, K, R), and acidic (D, E) residues. The
length of peptides and the isoelectric point (pI) were also considered.<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> The dimension of this feature vector is 10.</p>
      </sec>
      <sec id="sec4.3.2">
        <title>CTD-Based Features</title>
        <p>This feature set contains 237 features
(39C, 39T, 139D) characterizing the composition, transition, and distribution
of the particular properties, wherein the amino acids are divided
into clusters based on particular properties, such as hydrophobicity,
normalized van der Waals volume, polarity, polarizability, charge,
secondary structure, and solvent accessibility of peptide sequences.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p>
      </sec>
      <sec id="sec4.3.3">
        <title><sup>13</sup>C NMR-Based Features</title>
        <p>In this respect,
the features extracted from the <sup>13</sup>C NMR spectra (with the
exception of tyrosine), for instance, relative spectral power, slow
wave index, and harmonic parameters, were used to cluster the amino
acids. We have already demonstrated the discriminating power of this
feature vector in the prediction of antimicrobial and biofilm-inhibiting
peptides.<sup><xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref74">74</xref></sup></p>
      </sec>
    </sec>
    <sec id="sec4.4">
      <title>Feature Selection</title>
      <p>In the first and rather straightforward
approach (METH 1), various feature groups, such as AAC, DPC, GDPC,
CKSAAGP, PAAC, APAAC, PCP, CTD, and <sup>13</sup>C NMR, and seven
hybrids thereof were generated and evaluated on the machine learning
models. In the second method (METH 2), a multilayer selection procedure
was applied with the combination of filter-based and wrapper methods.
This feature selection algorithm consists of three layers. We used
the Mann–Whitney U test in the first layer to identify the
most discriminative features between the positive (class = 1) and
negative (class = 0) samples based on their <italic>p</italic>-values.
After this initial filtering, we applied the minimum redundancy maximum
relevance (mRMR) method to select the feature subsets according to
their importance and similarity.<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> This
algorithm tends to select a subset of features with higher relevance
to dependent variables (target class), though in a lower correlation
with each other. Accordingly, the highly correlated features were
discarded to avoid overfitting and false predictions. Finally, the
RFE was employed to identify the best features from the previous stage
candidate list. The RFE is a wrapper selection method that fits a
model and removes the weakest features until a specified number of
features are achieved. By the end of this selection method, 378 and
128 features were obtained for ACPs and CPPs, respectively.</p>
    </sec>
    <sec id="sec4.5">
      <title>Machine
Learning Model</title>
      <p>The SVM, RF, and XGBoost classifiers
were utilized to develop the predictor models. The standard GridSearchCV
method from the Scikit-learn package,<sup><xref ref-type="bibr" rid="ref76">76</xref></sup> taking a cross-validation generator (parameter “cv”),
was used and executed in 10 iterations to find the best set of hyperparameters
based on the AUC performance metric (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). The optimal parameters were obtained by
testing a wide variety of values.</p>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Optimal Parameters
for the Model Implementation
Using the Scikit-Learn Package<xref rid="t1fn1" ref-type="table-fn">a</xref></title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <tbody>
            <tr>
              <td rowspan="3" style="border:none;" align="left">SVM</td>
              <td style="border:none;" align="left"><italic>C</italic> = 10</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">γ = 0.01</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">kernel = rbf</td>
            </tr>
            <tr>
              <td rowspan="3" style="border:none;" align="left">RF</td>
              <td style="border:none;" align="left">number of estimators = 100</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">max depth = 8</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">criterion = entropy</td>
            </tr>
            <tr>
              <td rowspan="6" style="border:none;" align="left">XGBoost</td>
              <td style="border:none;" align="left">colsample_bytree = 0.2</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">γ = 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">learning rate = 0.1</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">max depth = 3</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">number of estimators = 100</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">subsample = 1</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t1fn1">
            <label>a</label>
            <p>The models were implemented in Python
3.7.<sup><xref ref-type="bibr" rid="ref76">76</xref></sup></p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>To predict the Cp-ACPs, however, the models were constructed
and
developed based on two subpredictors. Under this strategy, the active
ACPs and CPPs were independently identified, and then, a fusion method
through an intersection between the ACP and CPP classifiers’
results was utilized to identify the Cp-ACP sequences (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>).</p>
      <fig id="sch1" position="float">
        <label>Scheme 1</label>
        <caption>
          <title>Schematic Representation
of the CpACpP Model</title>
          <p id="s1fn1">The classification of Cp-ACPs
was generated through an intersection between two independently trained
ACP and CPP classifiers’ outcomes.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_0010" id="gr1" position="float"/>
      </fig>
    </sec>
    <sec id="sec4.6">
      <title>Performance
Evaluation</title>
      <p>Each independent ACP and CPP
was randomly split into 80% training and 20% testing subsets in 10
iterations. The model was trained only on the corresponding 80% training
data set, through which the 10-fold cross-validation was applied on
them to evaluate the models under the best hyperparameter setting.
In this regard, the training set was randomly split into 10 equal
subsamples, in which 9 samples were used as the training sets, and
the remaining one was used to build the prediction model. In the next
step, finally, the first 20% testing subset washeld out from the primary
training set and used as independent data to assess the trained models
and ensure that they execute fair predictions on the future unseen
sequences and meet superior generalization performance. This process
was executed 10 times to avoid our predictor overfitting. Finally,
the models were tested for the independent hold-out validation of
the Cp-ACP data set to independently evaluate the generalization power
of each classifier.</p>
      <p>Precision (PR), sensitivity (SN), specificity
(SP) equal to the true positive rate (TPR), accuracy (ACC), and F1
score were used to quantify the performance of our predicting models.
The MCC was also calculated to be used in imbalanced data sets. These
measures were defined in terms of true positive (TP), true negative
(TN), false positive (FP), and false negative (FN). The calculation
of each performance metric is demonstrated in <xref rid="eq6" ref-type="disp-formula">eq <xref rid="eq6" ref-type="disp-formula">6</xref></xref>.<disp-formula id="eq6"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m009" position="anchor"/><label>6</label></disp-formula></p>
      <p>Furthermore,
the receiver operating characteristic (ROC) curve
and the area under the ROC curve (AUC; see <xref rid="eq7" ref-type="disp-formula">eq <xref rid="eq7" ref-type="disp-formula">7</xref></xref>) were utilized to assess the predictor’s
performance, where false positive rate (FPR) means the fraction of
negative instances misclassified as positive.<disp-formula id="eq7"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_m010" position="anchor"/><label>7</label></disp-formula></p>
    </sec>
    <sec sec-type="data-availability" id="sec4.7">
      <title>Data and Software Availability</title>
      <p>A ready-to-use package
containing all supervised machine learning algorithms including the
scripts and instructions, as well as the data sets used in this study
(i.e., ACPs, NACPs, CPPs, NCPP, Cp-ACPs, NCp-ACPs), could be found
in the Supporting Information. Additionally, an interactive Web-based
application that allows access to unpredicted data with our trained
machines is accessible at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://cbb1.ut.ac.ir/CpACpP/Index">http://cbb1.ut.ac.ir/CpACpP/Index</uri>.</p>
    </sec>
  </sec>
</body>
<back>
  <notes id="notes-1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsomega.1c02569?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsomega.1c02569</ext-link>.<list id="silist" list-type="simple"><list-item><p>List of practically validated
Cp-ACPs, complete list
of PCPs of interest for the active and nonactive sequences, performance
result comparisons of the proposed ACP- and CPP-based predictors based
on the HYBR2 and METH 2 feature sets relative to other classifiers,
and the list of nonactive ACP and CPP sequences used for model training
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_001.pdf">PDF</ext-link>)</p></list-item><list-item><p>Machine
learning algorithms including the scripts and
instructions, as well as the data sets used in this study (i.e., ACPs,
NACPs, CPPs, NCPP, Cp-ACPs, NCp-ACPs) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.1c02569/suppl_file/ao1c02569_si_002.zip">ZIP</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_si_001.pdf">
        <caption>
          <p>ao1c02569_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="sifile2">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao1c02569_si_002.zip">
        <caption>
          <p>ao1c02569_si_002.zip</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes-2">
    <title>Author Contributions</title>
    <p>F.N., F.F.A.,
and S.B. equally contributed to the data-set preparation/analysis
and machine learning studies. S.B. configured the CpACpP Web server.
The manuscript was written and reviewed by all of the authors.</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d7e2098-autogenerated">
    <p>The authors declare no
competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This work was supported by financial grants from the
University
of Tehran (M.B. and K.K.) and the Iran National Science Foundation
(M.B.; funding no. 97009976).</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Siegel</surname><given-names>R. L.</given-names></name>; <name><surname>Miller</surname><given-names>K. D.</given-names></name>; <name><surname>Jemal</surname><given-names>A.</given-names></name><article-title>Cancer Statistics,
2020</article-title>. <source>Ca-Cancer J. Clin.</source><year>2020</year>, <volume>70</volume>, <fpage>7</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21590</pub-id>.<pub-id pub-id-type="pmid">31912902</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Vasan</surname><given-names>N.</given-names></name>; <name><surname>Baselga</surname><given-names>J.</given-names></name>; <name><surname>Hyman</surname><given-names>D. M.</given-names></name><article-title>A View on Drug Resistance in Cancer</article-title>. <source>Nature</source><year>2019</year>, <volume>575</volume>, <fpage>299</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1730-1</pub-id>.<pub-id pub-id-type="pmid">31723286</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Gabernet</surname><given-names>G.</given-names></name>; <name><surname>Müller</surname><given-names>A. T.</given-names></name>; <name><surname>Hiss</surname><given-names>J. A.</given-names></name>; <name><surname>Schneider</surname><given-names>G.</given-names></name><article-title>Membranolytic
Anticancer Peptides</article-title>. <source>MedChemComm</source><year>2016</year>, <volume>7</volume>, <fpage>2232</fpage>–<lpage>2245</lpage>. <pub-id pub-id-type="doi">10.1039/C6MD00376A</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Gaspar</surname><given-names>D.</given-names></name>; <name><surname>Veiga</surname><given-names>A. S.</given-names></name>; <name><surname>Castanho</surname><given-names>M. A. R. B.</given-names></name><article-title>From Antimicrobial to Anticancer
Peptides. A Review</article-title>. <source>Front. Microbiol.</source><year>2013</year>, <volume>4</volume>, <elocation-id>294</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2013.00294</pub-id>.<pub-id pub-id-type="pmid">24101917</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Ishikawa</surname><given-names>K.</given-names></name>; <name><surname>Medina</surname><given-names>S. H.</given-names></name>; <name><surname>Schneider</surname><given-names>J. P.</given-names></name>; <name><surname>Klar</surname><given-names>A. J. S.</given-names></name><article-title>Glycan Alteration
Imparts Cellular Resistance to a Membrane-Lytic Anticancer Peptide</article-title>. <source>Cell Chem. Biol.</source><year>2017</year>, <volume>24</volume>, <fpage>149</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2016.12.009</pub-id>.<pub-id pub-id-type="pmid">28089756</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Kay</surname><given-names>J.</given-names></name>; <name><surname>Thadhani</surname><given-names>E.</given-names></name>; <name><surname>Samson</surname><given-names>L.</given-names></name>; <name><surname>Engelward</surname><given-names>B.</given-names></name><article-title>Inflammation-Induced
DNA Damage, Mutations and Cancer</article-title>. <source>DNA Repair</source><year>2019</year>, <volume>83</volume>, <elocation-id>102673</elocation-id><pub-id pub-id-type="doi">10.1016/j.dnarep.2019.102673</pub-id>.<pub-id pub-id-type="pmid">31387777</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="book" id="cit7"><person-group person-group-type="allauthors"><name><surname>Ciobanasu</surname><given-names>C.</given-names></name>; <name><surname>Kubitscheck</surname><given-names>U.</given-names></name></person-group><article-title>Cell-Penetrating
Peptides Targeting and Distorting Biological Membranes</article-title>. In <source>Surface and Interface Science</source>; <publisher-name>Wiley</publisher-name>, <year>2020</year>; pp <fpage>441</fpage>–<lpage>469</lpage>.</mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Behzadi</surname><given-names>M.</given-names></name>; <name><surname>Arasteh</surname><given-names>S.</given-names></name>; <name><surname>Bagheri</surname><given-names>M.</given-names></name><article-title>Palmitoylation
of Membrane-Penetrating
Magainin Derivatives Reinforces Necroptosis in A549 Cells Dependent
on Peptide Conformational Propensities</article-title>. <source>ACS
Appl. Mater. Interfaces</source><year>2020</year>, <volume>12</volume>, <fpage>56815</fpage>–<lpage>56829</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.0c17648</pub-id>.<pub-id pub-id-type="pmid">33296603</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Wu</surname><given-names>D.</given-names></name>; <name><surname>Gao</surname><given-names>Y.</given-names></name>; <name><surname>Qi</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>L.</given-names></name>; <name><surname>Ma</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name><article-title>Peptide-Based
Cancer Therapy: Opportunity and Challenge</article-title>. <source>Cancer
Lett.</source><year>2014</year>, <volume>351</volume>, <fpage>13</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2014.05.002</pub-id>.<pub-id pub-id-type="pmid">24836189</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Maraming</surname><given-names>P.</given-names></name>; <name><surname>Klaynongsruang</surname><given-names>S.</given-names></name>; <name><surname>Boonsiri</surname><given-names>P.</given-names></name>; <name><surname>Peng</surname><given-names>S. F.</given-names></name>; <name><surname>Daduang</surname><given-names>S.</given-names></name>; <name><surname>Leelayuwat</surname><given-names>C.</given-names></name>; <name><surname>Pientong</surname><given-names>C.</given-names></name>; <name><surname>Chung</surname><given-names>J. G.</given-names></name>; <name><surname>Daduang</surname><given-names>J.</given-names></name><article-title>The Cationic
Cell-Penetrating KT2 Peptide Promotes Cell Membrane Defects and Apoptosis
with Autophagy Inhibition in Human HCT 116 Colon Cancer Cells</article-title>. <source>J. Cell Physiol.</source><year>2019</year>, <volume>234</volume>, <fpage>22116</fpage>–<lpage>22129</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.28774</pub-id>.<pub-id pub-id-type="pmid">31073999</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Wang</surname><given-names>C.</given-names></name>; <name><surname>Dong</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>L.</given-names></name>; <name><surname>Gong</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Shang</surname><given-names>D.</given-names></name><article-title>Cell Surface Binding,
Uptaking and Anticancer Activity of L-K6, a Lysine/Leucine-Rich Peptide,
on Human Breast Cancer MCF-7 Cells</article-title>. <source>Sci. Rep.</source><year>2017</year>, <volume>7</volume>, <elocation-id>8293</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-08963-2</pub-id>.<pub-id pub-id-type="pmid">28811617</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Yamada</surname><given-names>T.</given-names></name>; <name><surname>Das Gupta</surname><given-names>T. K.</given-names></name>; <name><surname>Beattie</surname><given-names>C. W.</given-names></name><article-title>P28, an Anionic Cell-Penetrating
Peptide, Increases the Activity of Wild Type and Mutated P53 without
Altering Its Conformation</article-title>. <source>Mol. Pharmaceutics</source><year>2013</year>, <volume>10</volume>, <fpage>3375</fpage>–<lpage>3383</lpage>. <pub-id pub-id-type="doi">10.1021/mp400221r</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Basith</surname><given-names>S.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Hwan Shin</surname><given-names>T.</given-names></name>; <name><surname>Lee</surname><given-names>G.</given-names></name><article-title>Machine Intelligence
in Peptide Therapeutics: A Next-generation Tool for Rapid Disease
Screening</article-title>. <source>Med. Res. Rev.</source><year>2020</year>, <volume>40</volume>, <fpage>1276</fpage>–<lpage>1314</lpage>. <pub-id pub-id-type="doi">10.1002/med.21658</pub-id>.<pub-id pub-id-type="pmid">31922268</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Liang</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>F.</given-names></name>; <name><surname>Chen</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Song</surname><given-names>J.</given-names></name>; <name><surname>Liu</surname><given-names>Q.</given-names></name><article-title>Large-Scale Comparative Review and
Assessment of Computational Methods for Anti-Cancer Peptide Identification</article-title>. <source>Briefings Bioinf.</source><year>2020</year>, <elocation-id>bbaa312</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbaa312</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Su</surname><given-names>R.</given-names></name>; <name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Zou</surname><given-names>Q.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Wei</surname><given-names>L.</given-names></name><article-title>Empirical Comparison
and Analysis of Web-Based Cell-Penetrating Peptide Prediction Tools</article-title>. <source>Briefings Bioinf.</source><year>2020</year>, <volume>21</volume>, <fpage>408</fpage>–<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bby124</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="book" id="cit16"><person-group person-group-type="allauthors"><name><surname>Bedo</surname><given-names>J.</given-names></name>; <name><surname>Sanderson</surname><given-names>C.</given-names></name>; <name><surname>Kowalczyk</surname><given-names>A.</given-names></name></person-group><article-title>An
Efficient Alternative
to SVM Based Recursive Feature Elimination with Applications in Natural
Language Processing and Bioinformatics</article-title>. In <source>Australian Joint Conference on Artificial Intelligence: Advances
in Artificial Intelligence</source>; <person-group person-group-type="editor"><name><surname>Sattar</surname><given-names>A.</given-names></name>; <name><surname>Kang</surname><given-names>B.</given-names></name></person-group>, Eds.; <publisher-name>Springer</publisher-name>: <publisher-loc>Berlin, Heidelberg</publisher-loc>, <year>2006</year>; pp <fpage>170</fpage>–<lpage>180</lpage>.</mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Masoudi-Sobhanzadeh</surname><given-names>Y.</given-names></name>; <name><surname>Motieghader</surname><given-names>H.</given-names></name>; <name><surname>Masoudi-Nejad</surname><given-names>A.</given-names></name><article-title>FeatureSelect: A Software for Feature
Selection Based on Machine Learning Approaches</article-title>. <source>BMC Bioinformatics</source><year>2019</year>, <volume>20</volume>, <elocation-id>170</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-019-2754-0</pub-id>.<pub-id pub-id-type="pmid">30943889</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Tyagi</surname><given-names>A.</given-names></name>; <name><surname>Kapoor</surname><given-names>P.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P.</given-names></name><article-title>In Silico Models
for Designing and
Discovering Novel Anticancer Peptides</article-title>. <source>Sci.
Rep.</source><year>2013</year>, <volume>3</volume>, <elocation-id>2984</elocation-id><pub-id pub-id-type="doi">10.1038/srep02984</pub-id>.<pub-id pub-id-type="pmid">24136089</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Chen</surname><given-names>W.</given-names></name>; <name><surname>Ding</surname><given-names>H.</given-names></name>; <name><surname>Feng</surname><given-names>P.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name>; <name><surname>Chou</surname><given-names>K. C.</given-names></name><article-title>IACP: A
Sequence-Based Tool for Identifying Anticancer Peptides</article-title>. <source>Oncotarget</source><year>2016</year>, <volume>7</volume>, <fpage>16895</fpage>–<lpage>16909</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.7815</pub-id>.<pub-id pub-id-type="pmid">26942877</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Schaduangrat</surname><given-names>N.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Prachayasittikul</surname><given-names>V.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>ACPred: A
Computational Tool for the Prediction and Analysis of Anticancer Peptides</article-title>. <source>Molecules</source><year>2019</year>, <volume>24</volume>, <elocation-id>1973</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24101973</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Boopathi</surname><given-names>V.</given-names></name>; <name><surname>Subramaniyam</surname><given-names>S.</given-names></name>; <name><surname>Malik</surname><given-names>A.</given-names></name>; <name><surname>Lee</surname><given-names>G.</given-names></name>; <name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Yang</surname><given-names>D. C.</given-names></name><article-title>MACppred: A Support Vector Machine-Based Meta-Predictor
for Identification of Anticancer Peptides</article-title>. <source>Int.
J. Mol. Sci.</source><year>2019</year>, <volume>20</volume>, <elocation-id>1964</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20081964</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Kumar</surname><given-names>R.</given-names></name>; <name><surname>Sharma</surname><given-names>A.</given-names></name>; <name><surname>Kapoor</surname><given-names>P.</given-names></name>; <name><surname>Tyagi</surname><given-names>A.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P.</given-names></name><article-title>In Silico Approaches for Designing
Highly Effective Cell Penetrating Peptides</article-title>. <source>J. Transl. Med.</source><year>2013</year>, <volume>11</volume>, <elocation-id>74</elocation-id><pub-id pub-id-type="doi">10.1186/1479-5876-11-74</pub-id>.<pub-id pub-id-type="pmid">23517638</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Subramaniyam</surname><given-names>S.</given-names></name>; <name><surname>Shin</surname><given-names>T. H.</given-names></name>; <name><surname>Kim</surname><given-names>M. O.</given-names></name>; <name><surname>Lee</surname><given-names>G.</given-names></name><article-title>Machine-Learning-Based
Prediction of Cell-Penetrating Peptides and Their Uptake Efficiency
with Improved Accuracy</article-title>. <source>J. Proteome Res.</source><year>2018</year>, <volume>17</volume>, <fpage>2715</fpage>–<lpage>2726</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.8b00148</pub-id>.<pub-id pub-id-type="pmid">29893128</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Wei</surname><given-names>L.</given-names></name>; <name><surname>Xing</surname><given-names>P.</given-names></name>; <name><surname>Su</surname><given-names>R.</given-names></name>; <name><surname>Shi</surname><given-names>G.</given-names></name>; <name><surname>Ma</surname><given-names>Z. S.</given-names></name>; <name><surname>Zou</surname><given-names>Q.</given-names></name><article-title>CPPred-RF: A Sequence-Based Predictor
for Identifying Cell-Penetrating
Peptides and Their Uptake Efficiency</article-title>. <source>J. Proteome
Res.</source><year>2017</year>, <volume>16</volume>, <fpage>2044</fpage>–<lpage>2053</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.7b00019</pub-id>.<pub-id pub-id-type="pmid">28436664</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Wei</surname><given-names>L.</given-names></name>; <name><surname>Tang</surname><given-names>J.</given-names></name>; <name><surname>Zou</surname><given-names>Q.</given-names></name><article-title>SkipCPP-Pred:
An Improved and Promising
Sequence-Based Predictor for Predicting Cell-Penetrating Peptides</article-title>. <source>BMC Genomics</source><year>2017</year>, <volume>18</volume>, <elocation-id>742</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-017-4128-1</pub-id>.<pub-id pub-id-type="pmid">29513192</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Jenson</surname><given-names>J. M.</given-names></name>; <name><surname>Xue</surname><given-names>V.</given-names></name>; <name><surname>Stretz</surname><given-names>L.</given-names></name>; <name><surname>Mandal</surname><given-names>T.</given-names></name>; <name><surname>Reich</surname><given-names>L. L.</given-names></name>; <name><surname>Keating</surname><given-names>A. E.</given-names></name><article-title>Peptide
Design by Optimization on a Data-Parameterized Protein Interaction
Landscape</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2018</year>, <volume>115</volume>, <fpage>E10342</fpage>–<lpage>E10351</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1812939115</pub-id>.<pub-id pub-id-type="pmid">30322927</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Duong</surname><given-names>D. T.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Bagheri</surname><given-names>M.</given-names></name>; <name><surname>Verma</surname><given-names>N. K.</given-names></name>; <name><surname>Schmidtchen</surname><given-names>A.</given-names></name>; <name><surname>Malmsten</surname><given-names>M.</given-names></name><article-title>Pronounced Peptide Selectivity for
Melanoma through
Tryptophan End-Tagging</article-title>. <source>Sci. Rep.</source><year>2016</year>, <volume>6</volume>, <elocation-id>24952</elocation-id><pub-id pub-id-type="doi">10.1038/srep24952</pub-id>.<pub-id pub-id-type="pmid">27117225</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Pandey</surname><given-names>P.</given-names></name>; <name><surname>Patel</surname><given-names>V.</given-names></name>; <name><surname>George</surname><given-names>N. V.</given-names></name>; <name><surname>Mallajosyula</surname><given-names>S. S.</given-names></name><article-title>KELM-CPPpred:
Kernel Extreme Learning Machine Based Prediction Model for Cell-Penetrating
Peptides</article-title>. <source>J. Proteome Res.</source><year>2018</year>, <volume>17</volume>, <fpage>3214</fpage>–<lpage>3222</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.8b00322</pub-id>.<pub-id pub-id-type="pmid">30032609</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Liu</surname><given-names>X.</given-names></name>; <name><surname>Cao</surname><given-names>R.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Jia</surname><given-names>J.</given-names></name>; <name><surname>Fei</surname><given-names>H.</given-names></name><article-title>Amphipathicity
Determines
Different Cytotoxic Mechanisms of Lysine- or Arginine-Rich Cationic
Hydrophobic Peptides in Cancer Cells</article-title>. <source>J. Med.
Chem.</source><year>2016</year>, <volume>59</volume>, <fpage>5238</fpage>–<lpage>5247</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b02016</pub-id>.<pub-id pub-id-type="pmid">27195657</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Bechara</surname><given-names>C.</given-names></name>; <name><surname>Pallerla</surname><given-names>M.</given-names></name>; <name><surname>Zaltsman</surname><given-names>Y.</given-names></name>; <name><surname>Burlina</surname><given-names>F.</given-names></name>; <name><surname>Alves</surname><given-names>I. D.</given-names></name>; <name><surname>Lequin</surname><given-names>O.</given-names></name>; <name><surname>Sagan</surname><given-names>S.</given-names></name><article-title>Tryptophan
within Basic Peptide Sequences
Triggers Glycosaminoglycan- Dependent Endocytosis</article-title>. <source>FASEB J.</source><year>2013</year>, <volume>27</volume>, <fpage>738</fpage>–<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1096/fj.12-216176</pub-id>.<pub-id pub-id-type="pmid">23070606</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Milletti</surname><given-names>F.</given-names></name><article-title>Cell-Penetrating
Peptides: Classes, Origin, and Current Landscape</article-title>. <source>Drug Discovery Today</source><year>2012</year>, <volume>17</volume>, <fpage>850</fpage>–<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2012.03.002</pub-id>.<pub-id pub-id-type="pmid">22465171</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="weblink" id="cit32"><person-group person-group-type="allauthors"><name><surname>Waskom</surname><given-names>M.</given-names></name>; <name><surname>Botvinnik</surname><given-names>O.</given-names></name>; <name><surname>Gelbart</surname><given-names>M.</given-names></name>; <name><surname>Ostblom</surname><given-names>J.</given-names></name>; <name><surname>Hobson</surname><given-names>P.</given-names></name>; <name><surname>Lukauskas</surname><given-names>S.</given-names></name>; <name><surname>Gemperline</surname><given-names>D. C.</given-names></name>; <name><surname>Augspurger</surname><given-names>T.</given-names></name>; <name><surname>Halchenko</surname><given-names>Y.</given-names></name>; <name><surname>Warmenhoven</surname><given-names>J.</given-names></name>; <name><surname>Cole</surname><given-names>J.
B.</given-names></name>; <name><surname>Ruiter</surname><given-names>J.</given-names></name>; <name><surname>de Vanderplas</surname><given-names>J.</given-names></name>; <name><surname>Hoyer</surname><given-names>S.</given-names></name>; <name><surname>Pye</surname><given-names>C.</given-names></name>; <name><surname>Miles</surname><given-names>A.</given-names></name>; <name><surname>Swain</surname><given-names>C.</given-names></name>; <name><surname>Meyer</surname><given-names>K.</given-names></name>; <name><surname>Martin</surname><given-names>M.</given-names></name>; <name><surname>Bachant</surname><given-names>P.</given-names></name>; <name><surname>Quintero</surname><given-names>E.</given-names></name>; <name><surname>Kunter</surname><given-names>G.</given-names></name>; <name><surname>Villalba</surname><given-names>S.</given-names></name>; <name><surname>Brian</surname></name>; <name><surname>Fitzgerald</surname><given-names>C.</given-names></name>; <name><surname>Evans</surname><given-names>C. G.</given-names></name>; <name><surname>Williams</surname><given-names>M. L.</given-names></name>; <name><surname>O’Kane</surname><given-names>D.</given-names></name>; <name><surname>Yarkoni</surname><given-names>T.</given-names></name>; <name><surname>Brunner</surname><given-names>T.</given-names></name></person-group><article-title>mwaskom/seaborn: v0.11.0 (September
2020)</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://zenodo.org/record/4019146">https://zenodo.org/record/4019146</uri> (accessed Dec 30, <year>2020</year>).</mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Kourie</surname><given-names>J. I.</given-names></name>; <name><surname>Shorthouse</surname><given-names>A. A.</given-names></name><article-title>Properties
of Cytotoxic Peptide-Formed Ion Channels</article-title>. <source>Am.
J. Physiol.: Cell Physiol.</source><year>2000</year>, <volume>278</volume>, <fpage>C1063</fpage>–<lpage>C1087</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.2000.278.6.C1063</pub-id>.<pub-id pub-id-type="pmid">10837335</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Huang</surname><given-names>Y.-B.</given-names></name>; <name><surname>Wang</surname><given-names>X.-F.</given-names></name>; <name><surname>Wang</surname><given-names>H.-Y.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name><article-title>Studies on
Mechanism of Action of Anticancer Peptides by Modulation of Hydrophobicity
Within a Defined Structural Framework</article-title>. <source>Mol.
Cancer Ther.</source><year>2011</year>, <volume>10</volume>, <fpage>416</fpage>–<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-10-0811</pub-id>.<pub-id pub-id-type="pmid">21252288</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Neumann</surname><given-names>U.</given-names></name>; <name><surname>Riemenschneider</surname><given-names>M.</given-names></name>; <name><surname>Sowa</surname><given-names>J. P.</given-names></name>; <name><surname>Baars</surname><given-names>T.</given-names></name>; <name><surname>Kälsch</surname><given-names>J.</given-names></name>; <name><surname>Canbay</surname><given-names>A.</given-names></name>; <name><surname>Heider</surname><given-names>D.</given-names></name><article-title>Compensation of Feature Selection
Biases Accompanied with Improved Predictive Performance for Binary
Classification by Using a Novel Ensemble Feature Selection Approach</article-title>. <source>BioData Min.</source><year>2016</year>, <volume>9</volume>, <elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.1186/s13040-016-0114-4</pub-id>.<pub-id pub-id-type="pmid">27891179</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><name><surname>Chen</surname><given-names>Z.</given-names></name>; <name><surname>Zhao</surname><given-names>P.</given-names></name>; <name><surname>Li</surname><given-names>F.</given-names></name>; <name><surname>Leier</surname><given-names>A.</given-names></name>; <name><surname>Marquez-Lago</surname><given-names>T. T.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Webb</surname><given-names>G. I.</given-names></name>; <name><surname>Smith</surname><given-names>A. I.</given-names></name>; <name><surname>Daly</surname><given-names>R. J.</given-names></name>; <name><surname>Chou</surname><given-names>K.-C.</given-names></name>; <name><surname>Song</surname><given-names>J.</given-names></name><article-title>IFeature:
A Python Package and Web
Server for Features Extraction and Selection from Protein and Peptide
Sequences</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>2499</fpage>–<lpage>2502</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty140</pub-id>.<pub-id pub-id-type="pmid">29528364</pub-id></mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Müller</surname><given-names>A. T.</given-names></name>; <name><surname>Gabernet</surname><given-names>G.</given-names></name>; <name><surname>Hiss</surname><given-names>J. A.</given-names></name>; <name><surname>Schneider</surname><given-names>G.</given-names></name><article-title>ModlAMP: Python
for Antimicrobial Peptides</article-title>. <source>Bioinformatics</source><year>2017</year>, <volume>33</volume>, <fpage>2753</fpage>–<lpage>2755</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx285</pub-id>.<pub-id pub-id-type="pmid">28472272</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Kavousi</surname><given-names>K.</given-names></name>; <name><surname>Bagheri</surname><given-names>M.</given-names></name>; <name><surname>Behrouzi</surname><given-names>S.</given-names></name>; <name><surname>Vafadar</surname><given-names>S.</given-names></name>; <name><surname>Fallah Atanaki</surname><given-names>F.</given-names></name>; <name><surname>Teimoori Lotfabadi</surname><given-names>B.</given-names></name>; <name><surname>Ariaeenejad</surname><given-names>S.</given-names></name>; <name><surname>Shockravi</surname><given-names>A.</given-names></name>; <name><surname>Moosavi-Movahedi</surname><given-names>A. A.</given-names></name><article-title>IAMPE:
NMR Assisted Computational Prediction of Antimicrobial
Peptides</article-title>. <source>J. Chem. Inf. Model.</source><year>2020</year>, <volume>60</volume>, <fpage>4691</fpage>–<lpage>4701</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.0c00841</pub-id>.<pub-id pub-id-type="pmid">32946226</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Yang</surname><given-names>R.</given-names></name>; <name><surname>Zhang</surname><given-names>C.</given-names></name><article-title>Using a Classifier
Fusion Strategy
to Identify Anti-Angiogenic Peptides</article-title>. <source>Sci. Rep.</source><year>2018</year>, <volume>8</volume>, <elocation-id>14062</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-32443-w</pub-id>.<pub-id pub-id-type="pmid">30218091</pub-id></mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Yu</surname><given-names>G.</given-names></name>; <name><surname>Xia</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name><article-title>Protein-Protein Interactions Prediction
Based on Ensemble Deep Neural Networks</article-title>. <source>Neurocomputing</source><year>2019</year>, <volume>324</volume>, <fpage>10</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.neucom.2018.02.097</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Yu</surname><given-names>C.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>You</surname><given-names>Z.</given-names></name><article-title>An Ensemble
Classifier to Predict Protein–Protein Interactions by Combining
PSSM-Based Evolutionary Information with Local Binary Pattern Model</article-title>. <source>Int. J. Mol. Sci.</source><year>2019</year>, <volume>20</volume>, <elocation-id>3511</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20143511</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Nanni</surname><given-names>L.</given-names></name>; <name><surname>Lumini</surname><given-names>A.</given-names></name>; <name><surname>Brahnam</surname><given-names>S.</given-names></name><article-title>An Empirical
Study of Different Approaches
for Protein Classification</article-title>. <source>Sci. World J.</source><year>2014</year>, <volume>2014</volume>, <elocation-id>236717</elocation-id><pub-id pub-id-type="doi">10.1155/2014/236717</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Akbar</surname><given-names>S.</given-names></name>; <name><surname>Hayat</surname><given-names>M.</given-names></name>; <name><surname>Iqbal</surname><given-names>M.</given-names></name>; <name><surname>Jan</surname><given-names>M. A.</given-names></name><article-title>IACP-GAEnsC:
Evolutionary
Genetic Algorithm Based Ensemble Classification of Anticancer Peptides
by Utilizing Hybrid Feature Space</article-title>. <source>Artif. Intell.
Med.</source><year>2017</year>, <volume>79</volume>, <fpage>62</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.artmed.2017.06.008</pub-id>.<pub-id pub-id-type="pmid">28655440</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Fu</surname><given-names>X.</given-names></name>; <name><surname>Cai</surname><given-names>L.</given-names></name>; <name><surname>Zeng</surname><given-names>X.</given-names></name>; <name><surname>Zou</surname><given-names>Q.</given-names></name><article-title>StackCPPred: A Stacking and Pairwise
Energy Content-Based Prediction of Cell-Penetrating Peptides and Their
Uptake Efficiency</article-title>. <source>Bioinformatics</source><year>2020</year>, <volume>36</volume>, <fpage>3028</fpage>–<lpage>3034</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa131</pub-id>.<pub-id pub-id-type="pmid">32105326</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Herce</surname><given-names>H. D.</given-names></name>; <name><surname>Garcia</surname><given-names>A. E.</given-names></name>; <name><surname>Cardoso</surname><given-names>M. C.</given-names></name><article-title>Fundamental
Molecular Mechanism for
the Cellular Uptake of Guanidinium-Rich Molecules</article-title>. <source>J. Am. Chem. Soc.</source><year>2014</year>, <volume>136</volume>, <fpage>17459</fpage>–<lpage>17467</lpage>. <pub-id pub-id-type="doi">10.1021/ja507790z</pub-id>.<pub-id pub-id-type="pmid">25405895</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="journal" id="cit46"><name><surname>Schmidt</surname><given-names>N.
W.</given-names></name>; <name><surname>Lis</surname><given-names>M.</given-names></name>; <name><surname>Zhao</surname><given-names>K.</given-names></name>; <name><surname>Lai</surname><given-names>G. H.</given-names></name>; <name><surname>Alexandrova</surname><given-names>A. N.</given-names></name>; <name><surname>Tew</surname><given-names>G. N.</given-names></name>; <name><surname>Wong</surname><given-names>G. C. L.</given-names></name><article-title>Molecular Basis for Nanoscopic Membrane
Curvature Generation from Quantum Mechanical Models and Synthetic
Transporter Sequences</article-title>. <source>J. Am. Chem. Soc.</source><year>2012</year>, <volume>134</volume>, <fpage>19207</fpage>–<lpage>19216</lpage>. <pub-id pub-id-type="doi">10.1021/ja308459j</pub-id>.<pub-id pub-id-type="pmid">23061419</pub-id></mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Hirama</surname><given-names>T.</given-names></name>; <name><surname>Lu</surname><given-names>S. M.</given-names></name>; <name><surname>Kay</surname><given-names>J. G.</given-names></name>; <name><surname>Maekawa</surname><given-names>M.</given-names></name>; <name><surname>Kozlov</surname><given-names>M. M.</given-names></name>; <name><surname>Grinstein</surname><given-names>S.</given-names></name>; <name><surname>Fairn</surname><given-names>G. D.</given-names></name><article-title>Membrane Curvature Induced by Proximity
of Anionic Phospholipids Can Initiate Endocytosis</article-title>. <source>Nat. Commun.</source><year>2017</year>, <volume>8</volume>, <elocation-id>1393</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01554-9</pub-id>.<pub-id pub-id-type="pmid">29123120</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Fan</surname><given-names>R.</given-names></name>; <name><surname>Yuan</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Zhou</surname><given-names>X. R.</given-names></name>; <name><surname>Jia</surname><given-names>L.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Yu</surname><given-names>C.</given-names></name>; <name><surname>Luo</surname><given-names>S. Z.</given-names></name>; <name><surname>Chen</surname><given-names>L.</given-names></name><article-title>Isoleucine/Leucine
Residues at “a” and “d” Positions of a
Heptad Repeat Sequence Are Crucial for the Cytolytic Activity of a
Short Anticancer Lytic Peptide</article-title>. <source>Amino Acids</source><year>2017</year>, <volume>49</volume>, <fpage>193</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-016-2350-9</pub-id>.<pub-id pub-id-type="pmid">27778166</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Hayouka</surname><given-names>Z.</given-names></name>; <name><surname>Mortenson</surname><given-names>D. E.</given-names></name>; <name><surname>Kreitler</surname><given-names>D. F.</given-names></name>; <name><surname>Weisblum</surname><given-names>B.</given-names></name>; <name><surname>Forest</surname><given-names>K. T.</given-names></name>; <name><surname>Gellman</surname><given-names>S. H.</given-names></name><article-title>Evidence
for Phenylalanine Zipper-Mediated Dimerization
in the X-Ray Crystal Structure of a Magainin 2 Analogue</article-title>. <source>J. Am. Chem. Soc.</source><year>2013</year>, <volume>135</volume>, <fpage>15738</fpage>–<lpage>15741</lpage>. <pub-id pub-id-type="doi">10.1021/ja409082w</pub-id>.<pub-id pub-id-type="pmid">24102563</pub-id></mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Xu</surname><given-names>L.</given-names></name>; <name><surname>Chou</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Shao</surname><given-names>C.</given-names></name>; <name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Zhu</surname><given-names>X.</given-names></name>; <name><surname>Shan</surname><given-names>A.</given-names></name><article-title>Antimicrobial
Activity and Membrane-Active Mechanism
of Tryptophan Zipper-like β-Hairpin Antimicrobial Peptides</article-title>. <source>Amino Acids</source><year>2015</year>, <volume>47</volume>, <fpage>2385</fpage>–<lpage>2397</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-015-2029-7</pub-id>.<pub-id pub-id-type="pmid">26088720</pub-id></mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Bagheri</surname><given-names>M.</given-names></name>; <name><surname>Amininasab</surname><given-names>M.</given-names></name>; <name><surname>Dathe</surname><given-names>M.</given-names></name><article-title>Arginine/Tryptophan-Rich Cyclic α/β-Antimicrobial
Peptides: The Roles of Hydrogen Bonding and Hydrophobic/Hydrophilic
Solvent-Accessible Surface Areas upon Activity and Membrane Selectivity</article-title>. <source>Chem. - Eur. J.</source><year>2018</year>, <volume>24</volume>, <fpage>14242</fpage>–<lpage>14253</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201802881</pub-id>.<pub-id pub-id-type="pmid">29969522</pub-id></mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>Dhiman</surname><given-names>N.</given-names></name>; <name><surname>Shagaghi</surname><given-names>N.</given-names></name>; <name><surname>Bhave</surname><given-names>M.</given-names></name>; <name><surname>Sumer</surname><given-names>H.</given-names></name>; <name><surname>Kingshott</surname><given-names>P.</given-names></name>; <name><surname>Rath</surname><given-names>S. N.</given-names></name><article-title>Selective Cytotoxicity of a Novel Trp-Rich Peptide
against Lung Tumor Spheroids Encapsulated inside a 3D Microfluidic
Device</article-title>. <source>Adv. Biosyst.</source><year>2020</year>, <volume>4</volume>, <elocation-id>1900285</elocation-id><pub-id pub-id-type="doi">10.1002/adbi.201900285</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Miller</surname><given-names>S. E.</given-names></name>; <name><surname>Tsuji</surname><given-names>K.</given-names></name>; <name><surname>Abrams</surname><given-names>R. P. M.</given-names></name>; <name><surname>Burke</surname><given-names>T. R.</given-names></name>; <name><surname>Schneider</surname><given-names>J. P.</given-names></name><article-title>Uncoupling
the Folding-Function Paradigm of Lytic Peptides to Deliver Impermeable
Inhibitors of Intracellular Protein–Protein Interactions</article-title>. <source>J. Am. Chem. Soc.</source><year>2020</year>, <volume>142</volume>, <fpage>19950</fpage>–<lpage>19955</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.0c07921</pub-id>.<pub-id pub-id-type="pmid">33175531</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Müller</surname><given-names>A. T.</given-names></name>; <name><surname>Posselt</surname><given-names>G.</given-names></name>; <name><surname>Gabernet</surname><given-names>G.</given-names></name>; <name><surname>Neuhaus</surname><given-names>C.</given-names></name>; <name><surname>Bachler</surname><given-names>S.</given-names></name>; <name><surname>Blatter</surname><given-names>M.</given-names></name>; <name><surname>Pfeiffer</surname><given-names>B.</given-names></name>; <name><surname>Hiss</surname><given-names>J. A.</given-names></name>; <name><surname>Dittrich</surname><given-names>P. S.</given-names></name>; <name><surname>Altmann</surname><given-names>K. H.</given-names></name>; <name><surname>Wessler</surname><given-names>S.</given-names></name>; <name><surname>Schneider</surname><given-names>G.</given-names></name><article-title>Morphing of
Amphipathic Helices to Explore the Activity and Selectivity of Membranolytic
Antimicrobial Peptides</article-title>. <source>Biochemistry</source><year>2020</year>, <volume>59</volume>, <fpage>3772</fpage>–<lpage>3781</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biochem.0c00565</pub-id>.<pub-id pub-id-type="pmid">32936629</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Zhao</surname><given-names>H.</given-names></name>; <name><surname>Qin</surname><given-names>X.</given-names></name>; <name><surname>Yang</surname><given-names>D.</given-names></name>; <name><surname>Jiang</surname><given-names>Y.</given-names></name>; <name><surname>Zheng</surname><given-names>W.</given-names></name>; <name><surname>Wang</surname><given-names>D.</given-names></name>; <name><surname>Tian</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>Q.</given-names></name>; <name><surname>Xu</surname><given-names>N.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name><article-title>The Development
of Activatable Lytic Peptides for Targeting Triple Negative Breast
Cancer</article-title>. <source>Cell Death Discovery</source><year>2017</year>, <volume>3</volume>, <elocation-id>17037</elocation-id><pub-id pub-id-type="doi">10.1038/cddiscovery.2017.37</pub-id>.<pub-id pub-id-type="pmid">29263848</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Hajisharifi</surname><given-names>Z.</given-names></name>; <name><surname>Piryaiee</surname><given-names>M.</given-names></name>; <name><surname>Mohammad Beigi</surname><given-names>M.</given-names></name>; <name><surname>Behbahani</surname><given-names>M.</given-names></name>; <name><surname>Mohabatkar</surname><given-names>H.</given-names></name><article-title>Predicting Anticancer Peptides with
Chou’s Pseudo
Amino Acid Composition and Investigating Their Mutagenicity via Ames
Test</article-title>. <source>J. Theor. Biol.</source><year>2014</year>, <volume>341</volume>, <fpage>34</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtbi.2013.08.037</pub-id>.<pub-id pub-id-type="pmid">24035842</pub-id></mixed-citation>
    </ref>
    <ref id="ref57">
      <mixed-citation publication-type="journal" id="cit57"><name><surname>Wei</surname><given-names>L.</given-names></name>; <name><surname>Zhou</surname><given-names>C.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Song</surname><given-names>J.</given-names></name>; <name><surname>Su</surname><given-names>R.</given-names></name><article-title>ACPred-FL:
A Sequence-Based Predictor Using Effective Feature Representation
to Improve the Prediction of Anti-Cancer Peptides</article-title>. <source>Bioinformatics</source><year>2018</year>, <volume>34</volume>, <fpage>4007</fpage>–<lpage>4016</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty451</pub-id>.<pub-id pub-id-type="pmid">29868903</pub-id></mixed-citation>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Rao</surname><given-names>B.</given-names></name>; <name><surname>Zhou</surname><given-names>C.</given-names></name>; <name><surname>Zhang</surname><given-names>G.</given-names></name>; <name><surname>Su</surname><given-names>R.</given-names></name>; <name><surname>Wei</surname><given-names>L.</given-names></name><article-title>ACPred-Fuse:
Fusing Multi-View Information Improves the Prediction of Anticancer
Peptides</article-title>. <source>Briefings Bioinf.</source><year>2020</year>, <volume>21</volume>, <fpage>1846</fpage>–<lpage>1855</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbz088</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Yi</surname><given-names>H.-C.</given-names></name>; <name><surname>You</surname><given-names>Z.-H.</given-names></name>; <name><surname>Zhou</surname><given-names>X.</given-names></name>; <name><surname>Cheng</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Jiang</surname><given-names>T.-H.</given-names></name>; <name><surname>Chen</surname><given-names>Z.-H.</given-names></name><article-title>ACP-DL: A Deep Learning Long Short-Term
Memory Model to Predict Anticancer Peptides Using High-Efficiency
Feature Representation</article-title>. <source>Mol. Ther.--Nucleic
Acids</source><year>2019</year>, <volume>17</volume>, <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.omtn.2019.04.025</pub-id>.<pub-id pub-id-type="pmid">31173946</pub-id></mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Yu</surname><given-names>L.</given-names></name>; <name><surname>Jing</surname><given-names>R.</given-names></name>; <name><surname>Liu</surname><given-names>F.</given-names></name>; <name><surname>Luo</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name><article-title>DeepACP: A
Novel Computational Approach for Accurate Identification of Anticancer
Peptides by Deep Learning Algorithm</article-title>. <source>Mol. Ther.--Nucleic
Acids</source><year>2020</year>, <volume>22</volume>, <fpage>862</fpage>–<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1016/j.omtn.2020.10.005</pub-id>.<pub-id pub-id-type="pmid">33230481</pub-id></mixed-citation>
    </ref>
    <ref id="ref61">
      <mixed-citation publication-type="journal" id="cit61"><name><surname>Charoenkwan</surname><given-names>P.</given-names></name>; <name><surname>Chiangjong</surname><given-names>W.</given-names></name>; <name><surname>Lee</surname><given-names>V. S.</given-names></name>; <name><surname>Nantasenamat</surname><given-names>C.</given-names></name>; <name><surname>Hasan</surname><given-names>M. M.</given-names></name>; <name><surname>Shoombuatong</surname><given-names>W.</given-names></name><article-title>Improved Prediction
and Characterization
of Anticancer Activities of Peptides Using a Novel Flexible Scoring
Card Method</article-title>. <source>Sci. Rep.</source><year>2021</year>, <volume>11</volume>, <elocation-id>3017</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-82513-9</pub-id>.<pub-id pub-id-type="pmid">33542286</pub-id></mixed-citation>
    </ref>
    <ref id="ref62">
      <mixed-citation publication-type="journal" id="cit62"><name><surname>Arif</surname><given-names>M.</given-names></name>; <name><surname>Ahmad</surname><given-names>S.</given-names></name>; <name><surname>Ali</surname><given-names>F.</given-names></name>; <name><surname>Fang</surname><given-names>G.</given-names></name>; <name><surname>Li</surname><given-names>M.</given-names></name>; <name><surname>Yu</surname><given-names>D. J.</given-names></name><article-title>TargetCPP: Accurate Prediction of Cell-Penetrating
Peptides from
Optimized Multi-Scale Features Using Gradient Boost Decision Tree</article-title>. <source>J. Comput.-Aided Mol. Des.</source><year>2020</year>, <volume>34</volume>, <fpage>841</fpage>–<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-020-00307-z</pub-id>.<pub-id pub-id-type="pmid">32180124</pub-id></mixed-citation>
    </ref>
    <ref id="ref63">
      <mixed-citation publication-type="journal" id="cit63"><name><surname>Capecchi</surname><given-names>A.</given-names></name>; <name><surname>Cai</surname><given-names>X.</given-names></name>; <name><surname>Personne</surname><given-names>H.</given-names></name>; <name><surname>Köhler</surname><given-names>T.</given-names></name>; <name><surname>van Delden</surname><given-names>C.</given-names></name>; <name><surname>Reymond</surname><given-names>J.-L.</given-names></name><article-title>Machine Learning Designs Non-Hemolytic
Antimicrobial
Peptides</article-title>. <source>Chem. Sci.</source><year>2021</year>, <volume>12</volume>, <fpage>9221</fpage>–<lpage>9232</lpage>. <pub-id pub-id-type="doi">10.1039/d1sc01713f</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref64">
      <mixed-citation publication-type="journal" id="cit64"><name><surname>Bhadra</surname><given-names>P.</given-names></name>; <name><surname>Yan</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Fong</surname><given-names>S.</given-names></name>; <name><surname>Siu</surname><given-names>S. W. I.</given-names></name><article-title>AmPEP: Sequence-Based
Prediction of Antimicrobial Peptides Using Distribution Patterns of
Amino Acid Properties and Random Forest</article-title>. <source>Sci.
Rep.</source><year>2018</year>, <volume>8</volume>, <elocation-id>1697</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-19752-w</pub-id>.<pub-id pub-id-type="pmid">29374199</pub-id></mixed-citation>
    </ref>
    <ref id="ref65">
      <mixed-citation publication-type="journal" id="cit65"><name><surname>Torrent</surname><given-names>M.</given-names></name>; <name><surname>Andreu</surname><given-names>D.</given-names></name>; <name><surname>Nogués</surname><given-names>V. M.</given-names></name>; <name><surname>Boix</surname><given-names>E.</given-names></name><article-title>Connecting Peptide
Physicochemical and Antimicrobial Properties by a Rational Prediction
Model</article-title>. <source>PLoS One</source><year>2011</year>, <volume>6</volume>, <elocation-id>e16968</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0016968</pub-id>.<pub-id pub-id-type="pmid">21347392</pub-id></mixed-citation>
    </ref>
    <ref id="ref66">
      <mixed-citation publication-type="journal" id="cit66"><name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Ding</surname><given-names>Y.</given-names></name>; <name><surname>Wen</surname><given-names>H.</given-names></name>; <name><surname>Lin</surname><given-names>Y.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Xia</surname><given-names>Q.</given-names></name>; <name><surname>Lin</surname><given-names>Z.</given-names></name><article-title>QSAR Modeling and Design
of Cationic Antimicrobial Peptides Based on Structural Properties
of Amino Acids</article-title>. <source>Comb. Chem. High Throughput
Screening</source><year>2012</year>, <volume>15</volume>, <fpage>347</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.2174/138620712799361807</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref67">
      <mixed-citation publication-type="journal" id="cit67"><name><surname>Huang</surname><given-names>Y.</given-names></name>; <name><surname>Niu</surname><given-names>B.</given-names></name>; <name><surname>Gao</surname><given-names>Y.</given-names></name>; <name><surname>Fu</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>W.</given-names></name><article-title>CD-HIT Suite: A Web
Server for Clustering and Comparing Biological Sequences</article-title>. <source>Bioinformatics</source><year>2010</year>, <volume>26</volume>, <fpage>680</fpage>–<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq003</pub-id>.<pub-id pub-id-type="pmid">20053844</pub-id></mixed-citation>
    </ref>
    <ref id="ref68">
      <mixed-citation publication-type="journal" id="cit68"><name><surname>Tyagi</surname><given-names>A.</given-names></name>; <name><surname>Tuknait</surname><given-names>A.</given-names></name>; <name><surname>Anand</surname><given-names>P.</given-names></name>; <name><surname>Gupta</surname><given-names>S.</given-names></name>; <name><surname>Sharma</surname><given-names>M.</given-names></name>; <name><surname>Mathur</surname><given-names>D.</given-names></name>; <name><surname>Joshi</surname><given-names>A.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><article-title>CancerPPD: A
Database of Anticancer Peptides and Proteins</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>, <volume>43</volume>, <fpage>D837</fpage>–<lpage>D843</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku892</pub-id>.<pub-id pub-id-type="pmid">25270878</pub-id></mixed-citation>
    </ref>
    <ref id="ref69">
      <mixed-citation publication-type="journal" id="cit69"><name><surname>Wang</surname><given-names>G.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name><article-title>APD3: The
Antimicrobial Peptide Database as a Tool
for Research and Education</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>, <volume>44</volume>, <fpage>D1087</fpage>–<lpage>D1093</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1278</pub-id>.<pub-id pub-id-type="pmid">26602694</pub-id></mixed-citation>
    </ref>
    <ref id="ref70">
      <mixed-citation publication-type="journal" id="cit70"><name><surname>Novković</surname><given-names>M.</given-names></name>; <name><surname>Simunić</surname><given-names>J.</given-names></name>; <name><surname>Bojović</surname><given-names>V.</given-names></name>; <name><surname>Tossi</surname><given-names>A.</given-names></name>; <name><surname>Juretić</surname><given-names>D.</given-names></name><article-title>DADP: The
Database of Anuran Defense Peptides</article-title>. <source>Bioinformatics</source><year>2012</year>, <volume>28</volume>, <fpage>1406</fpage>–<lpage>1407</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts141</pub-id>.<pub-id pub-id-type="pmid">22467909</pub-id></mixed-citation>
    </ref>
    <ref id="ref71">
      <mixed-citation publication-type="journal" id="cit71"><name><surname>Pirtskhalava</surname><given-names>M.</given-names></name>; <name><surname>Gabrielian</surname><given-names>A.</given-names></name>; <name><surname>Cruz</surname><given-names>P.</given-names></name>; <name><surname>Griggs</surname><given-names>H. L.</given-names></name>; <name><surname>Squires</surname><given-names>R. B.</given-names></name>; <name><surname>Hurt</surname><given-names>D. E.</given-names></name>; <name><surname>Grigolava</surname><given-names>M.</given-names></name>; <name><surname>Chubinidze</surname><given-names>M.</given-names></name>; <name><surname>Gogoladze</surname><given-names>G.</given-names></name>; <name><surname>Vishnepolsky</surname><given-names>B.</given-names></name>; <name><surname>Alekseev</surname><given-names>V.</given-names></name>; <name><surname>Rosenthal</surname><given-names>A.</given-names></name>; <name><surname>Tartakovsky</surname><given-names>M.</given-names></name><article-title>DBAASP v.2: An Enhanced Database of Structure and Antimicrobial/Cytotoxic
Activity of Natural and Synthetic Peptides</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>, <volume>44</volume>, <fpage>D1104</fpage>–<lpage>D1112</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1174</pub-id>.<pub-id pub-id-type="pmid">26578581</pub-id></mixed-citation>
    </ref>
    <ref id="ref72">
      <mixed-citation publication-type="journal" id="cit72"><name><surname>Agrawal</surname><given-names>P.</given-names></name>; <name><surname>Bhalla</surname><given-names>S.</given-names></name>; <name><surname>Usmani</surname><given-names>S. S.</given-names></name>; <name><surname>Singh</surname><given-names>S.</given-names></name>; <name><surname>Chaudhary</surname><given-names>K.</given-names></name>; <name><surname>Raghava</surname><given-names>G. P. S.</given-names></name>; <name><surname>Gautam</surname><given-names>A.</given-names></name><article-title>CPPsite 2.0:
A Repository of Experimentally
Validated Cell-Penetrating Peptides</article-title>. <source>Nucleic
Acids Res.</source><year>2016</year>, <volume>44</volume>, <fpage>D1098</fpage>–<lpage>D1103</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1266</pub-id>.<pub-id pub-id-type="pmid">26586798</pub-id></mixed-citation>
    </ref>
    <ref id="ref73">
      <mixed-citation publication-type="journal" id="cit73"><name><surname>Manavalan</surname><given-names>B.</given-names></name>; <name><surname>Basith</surname><given-names>S.</given-names></name>; <name><surname>Shin</surname><given-names>T. H.</given-names></name>; <name><surname>Choi</surname><given-names>S.</given-names></name>; <name><surname>Kim</surname><given-names>M. O.</given-names></name>; <name><surname>Lee</surname><given-names>G.</given-names></name><article-title>MLACP: Machine-Learning-Based
Prediction of Anticancer Peptides</article-title>. <source>Oncotarget</source><year>2017</year>, <volume>8</volume>, <fpage>77121</fpage>–<lpage>77136</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.20365</pub-id>.<pub-id pub-id-type="pmid">29100375</pub-id></mixed-citation>
    </ref>
    <ref id="ref74">
      <mixed-citation publication-type="journal" id="cit74"><name><surname>Fallah
Atanaki</surname><given-names>F.</given-names></name>; <name><surname>Behrouzi</surname><given-names>S.</given-names></name>; <name><surname>Ariaeenejad</surname><given-names>S.</given-names></name>; <name><surname>Boroomand</surname><given-names>A.</given-names></name>; <name><surname>Kavousi</surname><given-names>K.</given-names></name><article-title>BIPEP: Sequence-Based Prediction
of Biofilm Inhibitory Peptides Using a Combination of NMR and Physicochemical
Descriptors</article-title>. <source>ACS Omega</source><year>2020</year>, <volume>5</volume>, <fpage>7290</fpage>–<lpage>7297</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.9b04119</pub-id>.<pub-id pub-id-type="pmid">32280870</pub-id></mixed-citation>
    </ref>
    <ref id="ref75">
      <mixed-citation publication-type="journal" id="cit75"><name><surname>Yu</surname><given-names>L.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name><article-title>Efficient Feature Selection via Analysis of Relevance
and Redundancy</article-title>. <source>J. Mach. Learn. Res.</source><year>2004</year>, <volume>5</volume>, <fpage>1205</fpage>–<lpage>1224</lpage>.</mixed-citation>
    </ref>
    <ref id="ref76">
      <mixed-citation publication-type="journal" id="cit76"><name><surname>Pedregosa</surname><given-names>F.</given-names></name>; <name><surname>Varoquaux</surname><given-names>G.</given-names></name>; <name><surname>Gramfort</surname><given-names>A.</given-names></name>; <name><surname>Michel</surname><given-names>V.</given-names></name>; <name><surname>Thirion</surname><given-names>B.</given-names></name>; <name><surname>Grisel</surname><given-names>O.</given-names></name>; <name><surname>Blondel</surname><given-names>M.</given-names></name>; <name><surname>Prettenhofer</surname><given-names>P.</given-names></name>; <name><surname>Weiss</surname><given-names>R.</given-names></name>; <name><surname>Dubourg</surname><given-names>V.</given-names></name>; <name><surname>Vanderplas</surname><given-names>J.</given-names></name>; <name><surname>Passos</surname><given-names>A.</given-names></name>; <name><surname>Cournapeau</surname><given-names>D.</given-names></name>; <name><surname>Brucher</surname><given-names>M.</given-names></name>; <name><surname>Perrot</surname><given-names>M.</given-names></name>; <name><surname>Duchesnay</surname><given-names>É.</given-names></name><article-title>Scikit-Learn:
Machine Learning in Python</article-title>. <source>J. Mach. Learn.
Res.</source><year>2011</year>, <volume>12</volume>, <fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
  </ref-list>
</back>
